Adherence to cystic fibrosis treatment regimens: the association between health care provider relationship styles and self-efficacy, motivation to adhere and emotional well-being in adolescents and young adults by Squire, Jacqueline Victoria
ADHERENCE TO CYSTIC FIBROSIS TREATMENT
REGIMENS: THE ASSOCIATION BETWEEN HEALTH CARE
PROVIDER RELATIONSHIP STYLES AND SELF-EFFICACY,
MOTIVATION TO ADHERE AND EMOTIONAL WELL-BEING




SUBMITTED IN PART FULFILMENT OF THE DEGREE OF
DOCTORATE IN CLINICAL PSYCHOLOGY AT THE
UNIVERSITY OF EDINBURGH.
ACKNOWLEDGEMENTS
I would like to thank my Clinical Supervisor, Dr. Lesley Howells, and Dryden
Badenoch for their invaluable advice, support and encouragement throughout this
study. I would also like to thank my Academic Supervisor, Dr. Matthias
Schwannauer, and Arthur Still, statistician, for their helpful methodological and
statistical suggestions. In addition, I would like to acknowledge Dr. Somnath
Mukhopadhyay and Dr. Una MacFadyen, Consultant Paediatricians, and Dr. Winter
and Dr Innes, Consultant Respiratory Physicians, for their encouragement of this
study and assistance in recruiting participants and also Gail Milne, Mags Pogson and
Cathy Liddle, cystic fibrosis liaison nurses, for their help during the past few months,
especially during the data collection. Thanks to all the adolescents and young adults
with cystic fibrosis who gave their time to participate in the study and particularly to
those who were willing to speak honestly and in detail about their experiences.
Thanks also to my parents and sister for all their support throughout my clinical
training and to my friends Nicky, Rhona and Tom, especially, for providing words of
encouragement and laughs when they were much needed.
1
DECLARATION
"I certify that this is a true and accurate account of the work carried out. This thesis







Introduction: Cystic fibrosis (CF) is a chronic condition that requires an intensive
daily treatment regimen to control the symptoms and prolong life expectancy. Non-
adherence to treatment, however, has been documented within the literature and is a
major concern of health care professionals. Published studies investigating non-
adherence have tended to neglect the role of the patient-practitioner interaction. The
Self-determination Theory of Human Motivation (Deci and Ryan, 1985) highlights
the importance of autonomy supportive professional relationship styles in increasing
patients' self-efficacy and motivation for self-management. To date, no study has
applied this theory within the CF population.
Objectives: To examine whether there is an association between health care provider
relationship styles and self-efficacy and motivation to adhere in adolescents and
young adults with CF. Additionally, to investigate whether emotional well-being has
an effect on adherence to treatment regimens.
Design: A cross-sectional, investigative study was undertaken with CF patients, aged
between 12 and 30 years, attending out-patient CF clinics in Tayside and Forth
Valley.
Method: Participants completed four measures that assessed their perceptions of
health care providers' relationship styles, self-efficacy, motivation to adhere and
emotional well-being and provided a self-rating estimate of adherence. Semi-
structured interviews were conducted with a number of participants to gather more
detailed information regarding their personal experiences of CF. Demographic
information was obtained from participants' hospital case notes.
Results: As hypothesised, the results suggested that autonomy supportive
professional relationship styles were associated with increased motivation to adhere
and self-efficacy in adolescents and young adults with CF. Patient-practitioner
interactions should therefore be taken into consideration in future studies of
adherence. A thematic analysis of the interview data indicated that the participants'
experiences of CF were varied.
Conclusion: The research findings are discussed with reference to the current
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Cystic fibrosis (CF) is the most common life-threatening genetic disorder in the
United Kingdom (Chumbley, 1999) and is estimated to affect 1 in 2500 live births in
Caucasian populations (Walters, Britton and Hodson, 1993). In 1938, 70% of
children with CF died within the first year of life (Andersen, 1938). Flowever, the
prognosis of the condition has improved dramatically over the years due to earlier
diagnosis, the introduction of aggressive preventative medical treatment and changes
in the delivery of services allowing timely interventions to be made by health care
professionals. Non-adherence to CF treatment regimens has, however, been
documented within the literature with serious health implications for the individual
(Brown, Rowley and Helms, 1994). Recent studies have therefore become more
interested in examining factors that impact on and promote adherence behaviour to
treatment.
In the introduction to this study, general issues relating to CF, its treatment regimens
and problems with adherence will be addressed. The influence of emotional well-
being on adherence behaviours will be discussed and current literature regarding the
relationship between health care providers' interpersonal styles and patient self-
management will also be reviewed.
1.1 CYSTIC FIBROSIS
1.1.1 Introduction to Cystic Fibrosis
Cystic fibrosis is an autosomal recessive condition characterised by abnormal
secretions of the exocrine (mucus producing) glands that lead to problems within the
respiratory, pancreatic, gastro-intestinal and reproductive systems. Walters et al
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(1993) estimate that there are approximately 6500 individuals within the UK
presenting with the condition. Ethnic variations in the prevalence of CF are evident,
however, with the prevalence of live CF births at 1 in 17,000 in African American
populations and 1 in 90,000 in Oriental populations (Bush, 2001). CF requires time-
consuming and demanding daily treatment regimens that aim to control the
symptoms of the condition, delay further deterioration and improve the quality of life
of the patient thereby helping them and their family to live as normal and productive
a life as possible.
1.1.2 The Genetics of Cystic Fibrosis
CF has been recognised since the 1930's, although the CF gene was only identified
in 1989 (Cuthbert, 1996). CF results from a pair of faulty genes on the long arm of
chromosome 7. The gene normally produces a protein called Cystic Fibrosis
Transmembrane Conductance Regulator (CFTR) that carries sodium chloride and
water in and out of the cells lining the lungs and digestive tract. However, in CF the
gene may fail to produce any CFTR protein, resulting in problems in the way sodium
chloride and water are transported across the cell membranes and causing cell
secretions to be thick and sticky (Patientwise, 1997). Current estimates claim that
there are at least 200 different gene defects which give rise to the CF phenotype
therefore the condition can be difficult to diagnose by genetic screening.
Nevertheless, doctors and scientists are working to find ways of repairing or
replacing the faulty CF gene and although gene therapy is still in the early stages, it
provides hope for the future to patients and their families (Chumbley, 1999).
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1.1.3 Diagnostic Tests for Cystic Fibrosis
Chumbley (1999) postulates that if a child inherits a single CF gene on one
chromosome 7 and a normal gene on the other chromosome 7 then the child will be a
carrier of the CF gene but will display no symptoms as the normal gene compensates.
The chances of two CF carriers having a child with CF is estimated to be 25%, with a
50% chance that the offspring will be a carrier and a 25% chance that the child will
not inherit any faulty CF genes.
It is possible to screen parents for the CF genotype via a DNA test on a blood sample
or mouthwash and depending on the results, the health of their child can then be
monitored at antenatal clinics. Following birth, a diagnostic test commonly used if
CF is suspected is the sweat test. CF patients have a raised level of sodium chloride
in their sweat and the sweat test measures the amount of sodium chloride in the
secretions of the exocrine glands. Sweat chloride levels of greater than 60mmol are
considered to be diagnostic of CF with levels between 40-60mmol considered
'borderline' and levels below 40mmol perceived as 'normal' (Shwachman,
Mahmoodian and Neff, 1981). Bush (2001) also reports that measurements of sweat
sodium can be helpful as sweat sodium levels are usually higher than chloride within
the general population and therefore a reverse ratio in individuals suspected of
having CF would be another indication of the condition. Following the sweat test, the
diagnosis of CF is often confirmed by ascertaining the genotype of the patient.
Cuthbert (1996) posits that the Delta F508 CFTR mutation in the gene has been
detected in 70% of patients with CF in the UK.
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CF may also be suspected in newborn infants if there is evidence of intestinal
obstruction due to meconium ileus, the thick black substance that lines an unborn
baby's gut and is passed by all newborn babies the first time their bowels are opened.
In one in ten babies with CF, meconium ileus can be so thick and sticky that it blocks
the bowel, causing a swollen abdomen, abdominal pain, fatty stools and vomiting.
Bowel obstruction due to meconium ileus can also occur in babies without CF and
therefore confirmatory sweat testing is essential according to Fakhoury, Durie,
Levison and Canny (1992). Despite the diagnostic tests presently available, some
children can present with poor health for months or years before CF is suspected and
diagnosed. This can be physically costly as, for example, the administration of
antibiotic medication to prevent or quickly treat chest infections may be delayed and
subsequently the child's developing lungs could be permanently damaged. Delayed
diagnosis can also create emotional difficulties within families particularly if another
child with CF is born into a family without the parents having had an opportunity for
genetic counselling or antenatal diagnosis.
Recent developments in postnatal screening were publicised by the Scottish Health
Minister in October 2001 who announced that, from April 2002, all newborn babies
in the UK would be screened for CF as part of the Guthrie heel prick test. The
Guthrie heel prick test is carried out with every newborn baby aged between one and
two weeks to test for various conditions such as hypothyroidism and phenylketonuria
and CF was not previously included in this blood test. The inclusion of CF in
postnatal screening is a significant milestone that will enable children with CF to get
the best treatment at an early age, thereby extending their lifespan and enhancing
their quality of life (Hill, 1998).
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Around 80% of children with CF are diagnosed before four years of age having
presented with diarrhoea or fatty stools, failure to thrive, poor weight gain, recurrent
respiratory tract infections or a persistent cough (FitzSimmons, 1993). Variations in
the severity of the disease are evident, however, with some individuals requiring few
hospital admissions throughout their life whilst other individuals' health may be so
poor as to necessitate regular admissions. Generally, individuals diagnosed with CF
after 18 months of age are considered to have a milder form of the condition.
1.1.4 Life Expectancy
The life expectancy of individuals with CF has increased dramatically over the last
thirty years due to the earlier diagnosis of the condition, advances in medical and
scientific knowledge which have resulted in more effective treatments becoming
available and the development of specialised centres for the management of children
and adults with CF (Shale, 1996). However, it is still rare for individuals with CF to
have a normal life span. In 1991, Elborn, Shale and Britton conducted an
epidemiological analysis of CF patients and stated that more than 90% of children
born with CF in 1990 would reach adulthood with a life expectancy of 40 years. The
Cystic Fibrosis Foundation (1999) provides a more conservative estimate of life
expectancy of approximately 34 years for males and 31 years for females although
the reason for a poorer prognosis in females is unclear.
An increasing proportion of patients with CF are therefore surviving into adulthood.
However, a consequence of this increase in life expectancy is that many of these
individuals will experience additional problems to those encountered in children such
as complications with diabetes and liver disease, the development of additional
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infections such as Burkholderia Cepacia (Bush, 2001) or possible fertility problems
(Shale, 1996).
1.1.5 Clinical Features of Cystic Fibrosis and Available Treatments
CF affects the respiratory, pancreatic, gastro-intestinal and reproductive systems.
Problems presenting within each of these systems as a result of the condition will
now be discussed in detail in addition to current treatments available.
1.1.5.1 The Respiratory System
Respiratory disease is almost universal in the CF population. Penketh, Wise, Mearns,
Hodson and Balten (1987) studied 316 CF patients aged between 12 and 51 years
and reported that respiratory disease was present in 99.7% of the sample. Although
the lungs of CF patients are normal at birth, shortly after birth thick mucus is
produced in large quantities which block the small air tubes of the lungs and can
result in breathing difficulties and a constant cough. The thick mucus within the
lungs is believed to be the primary reason for the recurrence of chronic respiratory
infections. The mucus can become infected with a range of viruses that allow
bacteria and certain fungi to colonize within the respiratory tract leading to
secondary infection that causes production of additional mucus. Individuals with CF
also produce only small quantities of natural anti-bacterial chemicals within their
bodies and are therefore prone to persistent respiratory infections which can cause
lesions in the lung tissue over time and may ultimately lead to respiratory or heart
failure. Consequently, lung function tests are regularly conducted at CF clinics to
ascertain how well the lungs are functioning.
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Cough swabs or sputum samples are also taken within CF clinics during infections to
determine the bacteria present. The most feared broncho-pulmonary infection for
individuals with CF is Burkholderia cepacia which is resistant to virtually every
antibiotic and may cause a septicaemic illness in CF patients previously doing
relatively well (Lewin, Byard and Davis, 1990). In 1998, 3.5% of American CF
patients were known to be colonized with Burkholderia cepacia (Cystic Fibrosis
Foundation, 1999). Allergic broncho-pulmonary aspergillosis, characterised by the
plugging of the lobar and segmental bronchi with mucus, is also reported to affect
approximately 15% of CF patients and is a difficult fungus to treat (Shale, 1996). In
addition, Pseudomonas aeruginosa is becoming increasingly problematic within the
CF population, especially in individuals who have received multiple courses of
antibiotics. Although Pseudomonas aeruginosa is considered to be less infectious
than Burkholderia cepacia, Shale estimates that over 80% adults with CF will
eventually become colonized with the organism. Early, aggressive treatment delays
colonization but once present, eradication of the organism is not possible (Valerius,
Koch and Hoiby, 1991). Consequently, the initial colonization of Pseudomonas
aeruginosa is often seen as a watershed by patients and their families (Bush, 2001).
CF patients presenting with Burkholderia cepacia or Pseudomonas aeruginosa are
now segregated from other CF patients during hospital admissions and clinic
appointments to reduce the risk of spreading the bacteria. This action, however, can




1.1.5.2 Treatments Available for the Respiratory System
Current treatment for the respiratory system aims to keep the airways clear of
excessive secretions and cure infections quickly and effectively to prevent further
pulmonary deterioration.
Chest Physiotherapy
Chest physiotherapy has been described as the "cornerstone of treatment" for
respiratory disease (Chumbley, 1999). Physiotherapy techniques involve postural
drainage, percussion and directed coughing (Shale, 1996). These methods help to
dislodge the thick, sticky mucus from the lungs and enable the individual to
expectorate the secretions from the lungs. Physiotherapy also helps to prevent
pulmonary infection by loosening and removing the mucus secretions that obstruct
the airways and provide an environment for bacteria and viruses. The amount of
physiotherapy required depends on the individual's health but generally
physiotherapy is undertaken twice a day for ten to fifteen minutes, and even longer if
the individual has a chest infection since more mucus is produced. In addition to
physiotherapy, breathing techniques help to relax the airways and clear secretions
and the use of a PEP (Positive Expiratory Pressure) mask can assist patients to
achieve smooth and steady breathing patterns. Although parents are usually
responsible for administering physiotherapy in childhood, other family members and
friends are encouraged to learn the techniques so that the child is not solely
dependent on their parents. Physiotherapy is time-consuming and the incorporation





Some CF centres favour preventative medical treatment and commence children on
continuous oral antibiotics from infancy. Furthermore, they may advocate regular
three monthly courses of antibiotics regardless of the patient's current clinical state,
especially if the individual is colonized with Pseudomonas aeruginosa (Szaff, Floiby
and Flensborg, 1983). Other CF centres, however, prefer to introduce antibiotic
treatment during times of pulmonary infections to relieve the symptoms and reduce
inflammation. Antibiotics can be taken orally, through a nebulizer machine or via an
intravenous drip. Nebulized antibiotics are usually administered following
physiotherapy when the lungs have less mucus in them and the machine converts the
liquid medication into a fine mist which is inhaled directly into the lungs. If an
individual has a serious respiratory infection they may be admitted to hospital for a
course of antibiotics lasting a fortnight. Moreover, if frequent intravenous antibiotics
are required or there are problems with venous access, a port-a-cath can be inserted
into the patient's chest wall so that treatment can be administered at home or in
hospital, as and when required, without having to administer an injection every time.
Although port-a-caths are unobtrusive, adolescents in particular may be reluctant to
have one inserted due to concerns about body appearance. Furthermore, intravenous
antibiotics can be inconvenient to administer and are an additional burden to families
who already engage in time-consuming daily treatment regimens. Families are
therefore carefully assessed prior to deciding whether intravenous treatment should
be administered at home or in hospital. Nevertheless, enabling some individuals to
administer their intravenous antibiotics at home prevents them from spending long
periods away from their family as these can be difficult for all parties and can also be
disruptive to the patient's schooling or employment.
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In addition to antibiotic medication, many patients with CF take the enzyme DNase
through a nebulizer before physiotherapy to aid expectoration. DNase became
available in 1995 and breaks down and dilutes the mucus in the airways, making the
secretions more free-flowing and easier to clear by physiotherapy or directed
coughing. Bronchodilators can also be prescribed for use in a nebulizer machine
prior to physiotherapy, to aid sputum clearance by opening the airways.
A third of children with CF also present with asthmatic symptoms and require
medication such as corticosteroids which can be administered by either an inhaler or
a nebulizer. Corticosteroids reduce the inflammation in the airways and subsequently
reduce wheezing and relieve shortness of breath. However, Shale (1996) reports that
the continued use of inhaled corticosteroids can have considerable side effects such
as growth failure and the precipitation or deterioration of diabetes.
Exercise
Regular exercise is encouraged to provide a good supply of oxygen to the lungs to
enhance the individuals' ability to fight infections and help clear the sputum from the
lungs. A reduced exercise tolerance can also provide an indication of a deterioration
in the individual's lung function.
Lung Transplantation
Respiratory failure is the leading cause of morbidity and mortality in the CF
population and is responsible for 97% of all CF deaths and 75% of all hospital
admissions (Penketh et al, 1987). Tung function is commonly measured at CF clinics
by forced expiratory volume at one second (FEV1). Each CF patient is assigned a
11
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predicted FEV1 based on their gender, age and height and the FEV1 % predicted
gives an indication of the capacity to which the individual is functioning. Lung
transplantation will be suggested if a CF patient presents with a severe deterioration
in lung function, as indicated by a FEV1 of less than 30% of their predicted value,
requires increased hospitalisations, displays progressive weight loss and an impaired
quality of life (Dark and Corris, 1996). Bilateral lung transplantations are usually
undertaken due to the risk of spill-over infection if only one lung is replaced. Dark
and Corris report that the suggestion that a patient requires a lung transplant can be a
highly stressful time for both patients and their families as it implies that there is a
serious risk of death due to respiratory failure. Flowever, although complications can
arise post transplant, such as organ rejection and upper respiratory tract infections,
lung transplantation can be highly beneficial to patients with a 70-75% survival rate
one year after transplantation and a significant improvement in their quality of life
(Dark and Corris, 1996).
1.1.5.3 The Pancreatic System
Abnormally thick and sticky mucus is also developed within the pancreas in 89% of
individuals with CF resulting in pancreatic insufficiency (Penketh et al, 1987). The
pancreas is the digestive organ that lies behind the stomach and produces chemicals
called insulin and glucagons that control the amount of sugar in the blood and
produce digestive juices (pancreatic enzymes) that pass into the small intestine and
break down the fats, proteins and carbohydrates consumed so that they are absorbed.
In CF, the mucus produced obstructs the pancreas and hinders the digestive juices
from reaching the intestines to help break down and digest food, thereby preventing
the food from being properly absorbed. The mucus also prevents the digestive juices
12
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from neutralising the stomach acid leading to the development of cysts and fibrosis
(scarring and thickening) in the stomach. Pancreatic insufficiency is often recognised
by abdominal distension, abdominal pain, fatty and offensive smelling stools, a
failure to gain weight and appetite loss.
1.1.5.4 Treatments Available for the Pancreatic System
Pancreatic Enzymes
Due to pancreatic insufficiency, the majority of individuals with CF are required to
take pancreatic enzymes, such as Pancreatin or Creon, throughout their life with
every meal and snack to replace the missing enzymes and counter the digestive
problems and malnutrition that would otherwise result (Shale, 1996). Pancreatic
enzymes are administered in the form of medication, powder or capsules and are
released in the intestine to block the gastric acid secretion that reduces enzyme
activity and thereby to accelerate the breakdown of food for absorption. Individuals
are required to titrate the dose according to the size of the meal or snack they
consume and their faecal fat measurements. The correct dose can often take time to
establish although problems with constipation tend to indicate that too many
enzymes have been consumed. If pancreatic enzymes are missed regularly then
digestion is affected and the individual will be at risk of nutritional deficiency, will
fail to gain weight and may become lethargic. Poor weight gain and low energy
levels can, however, also result from the increased resting energy expenditure and





Due to the problems associated with the pancreas, individuals with CF are
encouraged to sustain a diet that is high in calories, fibre and fat with a recommended
calorie intake of 120-150% of the usual daily allowance, although additional calories
are required if the individual is unwell. Regular meals and snacks are also
encouraged with the aim ofmaintaining the individual's height and weight within the
normal range and preventing malnutrition and physical weakness (Nasr, 2000).
Improved nutrition can also benefit immunological status as fat is the most
concentrated source of energy and energy and protein intake need to be high to fight
infections (Bush, 2001). Better nutrition therefore results in fewer chest infections
and a slower deterioration of pulmonary function, thereby improving the chance of
surviving into adulthood (Cuthbert, 1996). If a CF patient exhibits extreme weight
loss they may require tube feeding to ensure a high-energy intake and improve their
weight gain. Tube feeding is often undertaken at night via a nasogastric tube or
gastrostomy directly into the stomach with the tube attached to a bag of calorie and
nutrient-enriched food. Feeding supplements such as Fortisip may also be
recommended.
Vitamin, Salt and Calcium Supplements
Vitamin deficiencies are common in patients with CF, particularly the fat-soluble
vitamins A, D, E and K (Shale, 1996). Due to the malabsorption of these vitamins
from foods consumed, vitamin supplements are usually required. Salt supplements
may also be necessary, especially in hot weather, because the significant amount of
salt lost in the individual's sweat puts them at risk of salt depletion, dehydration and
heat stroke. Furthermore, calcium supplements may be required due to a lack of fat-
14
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soluble minerals such as zinc as this can have a negative effect on the bones and put
the individual at risk of osteoporosis.
1.1.5.5 The Gastro-Intestinal System
One of the most common presentations of CF in newly born infants is meconium
ileus which, as mentioned earlier, is the substance that lines an unborn baby's gut
and is passed the first time their bowels are opened. However, meconium ileus can
be so thick and sticky in CF patients that it not only blocks the bowel but can lead to
a perforation of the gut. In older CF patients, the problem is generally referred to as
meconium ileus equivalent or distal intestinal obstruction syndrome and causes
temporary food intolerance, abdominal pain and constipation. In their report of 316
CF patients, Penketh et al (1987) claimed that acute meconium ileus equivalent was
evident in 16% of their sample and that a partial obstruction of the bowel was evident
in an additional 19% of the sample studied. Bush (2001) also asserts that individuals
with CF may have problems with an intestinal obstruction in later life due to poorly
digested food. In addition, CF patients may present with rectal prolapse, weakened
by the amount of bulky stools passed or the severe bouts of coughing experienced
due to respiratory infections. Treatment to alleviate intestinal obstructions usually
requires an enema or oral lactulose although surgery may be necessary in acute cases
to relieve the blockage or remove the blocked part of the bowel. Surgery may also be
required to relieve problems associated with a prolapse of the rectum.
1.1.5.6 The Reproductive System
Growth and puberty are delayed by about two years in individuals with CF although
sexual development is otherwise normal in both sexes (Reiter, Stern and Root, 1981).
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Female patients may present with a delayed menstrual cycle or amenorrhoea, partly
due to their low weight and partly due to the lack of nutrients within the body which
causes the body's systems to shut down to preserve the nutrients for those areas that
need them more urgently. Females with CF may therefore experience difficulty
conceiving due to this delay in menarche and also the mucus in their cervix that can
act as a barrier to sperm. Although many do conceive naturally or through assisted
conception and thereafter successfully carry their pregnancy to term, the
physiological stress of pregnancy and childbirth can put significant strain on the
female's cardio-pulmonary functioning (Edenborough, Stableforth, Webb,
Mackenzie and Smith, 1995). Generally clinical practice for medical staff is to advise
against pregnancy in women with poor respiratory function and low weight as they
may not gain adequate weight during pregnancy and could be at risk of death during
the stress of labour. With regard to male CF patients, Gotz and Gotz (2001) state that
infertility is almost universal due to the obstruction of the vas deferens with mucus.
Brugman and Tausig (1984) estimate that approximately 98% of males with CF are
infertile although state that in vitro fertilisation is possible in some cases if enough
sperm is obtained. Reproduction issues can place additional strain on adolescents and
young adults with CF compounding developmental changes already in existence at
this time of life. Furthermore, because these issues could subsequently have an effect
on the individual's ability to form and maintain relationships and impact on their





According to Shale (1996), the development of CF related diabetes during
adolescence or later life is a common complication for 30-50% of individuals with
CF because of pancreatic dysfunction which causes a deficiency in insulin and
results in abnormally high levels of sugar in the blood. CF related diabetes differs
from either Type 1 (insulin-dependent) or Type 2 (non-insulin dependent) diabetes as
it shares features of both types of diabetes (Nasr, 2000). The development of diabetes
can be an additional burden for CF patients as they have to contend with further
treatment regimens to those already required for their CF, such as regular glucose
testing and insulin injections. Nevertheless, the individual must continue with the
high calorie diet required for their CF condition as opposed to the standard diabetic
diet.
Liver Disease
There is evidence that mild liver disease is present in 29% of the adult CF population
(Penketh et al, 1987) and that the prevalence of this hepatobiliary complication
increases with age (Roy, 1983).
1.1.6 Service Delivery
Service delivery has developed in time with specialist CF clinics being created for
the management of children and adults with CF. Warwick (1982) states that
treatment appears to be most effective and life expectancy enhanced when health
care is delivered by a specialist team familiar with the patient. CF teams tend to be
multi-disciplinary in nature and include consultant respiratory physicians, CF liaison
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nurses, dieticians, physiotherapists and, occasionally, clinical psychologists and
pharmacists. This skill mix is considered to be an additional strength of specialist
teams. Clinics are generally held on a monthly basis and provide patients, and their
families where appropriate, with an opportunity to meet with each professional to
discuss issues relating to their health and current treatments. The CF liaison nurses
tend to meet with patients at their homes in between attending to them at the clinics
for routine check ups. The transfer from paediatric to adult CF clinics usually occurs
between the ages of 16 to 18 years (Westwood, Henley and Willcox, 1999). Nasr
(2000) states that this transition should be undertaken gradually and involve the
active participation of the patient, their family, the paediatrician and adult health care
providers. Rosen (1995) agrees and claims that the transfer to adult care is more
likely to be successful if it is well timed, is preceded by adequate groundwork and is
individually tailored for each patient. Support should also be made available for
parents at this time to allow them to voice any concerns about the transfer of
responsibility for the daily management of the condition to their child.
1.1.7 Summary
Individuals diagnosed with CF and their families have to learn to live with the
uncertainty of a chronic disease with an unpredictable prognosis and adapt their
lifestyles to incorporate intensive treatment regimens to maintain as normal a life as
possible. Improvements in the diagnosis of the condition and the early introduction
of treatments have resulted in prolonging the life expectancy of CF patients.
Consequently, it is likely that service provision for this population will require
continual expansion and greater attention will need to be focused on the physical and
psycho-social course of this disease from childhood into adulthood.
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1.2 ADHERENCE TO TREATMENT REGIMENS
1.2.1 Introduction to Adherence
Within the health care setting, treatment recommendations to improve the health
outcome of patients are made on the assumption that they will be adhered to. Many
studies, however, have demonstrated that adherence to treatment regimens is less
than optimal and clinicians often have difficulty in understanding why people do not
adhere to prescribed regimens, particularly in chronic health conditions (D'Angelo
and Lask, 2001). Conway, Pond, Hamnett and Watson (1996) advocate that it is
important to investigate the extent of non-adherence in health conditions and patient
characteristics associated with incomplete adherence so that these factors can be
considered when appraising a patient's condition and planning future treatment
programmes. By understanding the reasons why patients do or do not adhere to
treatment regimens, strategies can then be developed and applied by health care
professionals to promote self-care.
Adherence has been defined as "the extent to which a person's behaviour (in terms of
taking medications, following diets or executing lifestyle changes) coincides with
medical or health advice" (Haynes, 1979. pi-2). Rapoff (1999) asserts that this
definition is one of the most widely quoted in the literature as it focuses on specific
behaviours required in prescribed treatment regimens and does not view adherence as
an 'all or nothing' phenomenon but instead considers the concordance between what
the patient is being asked to do and what they actually do. The term 'compliance'
was utilised in early studies on adherence but was thought to imply an authoritarian
approach to health care, requiring unquestioned obedience by patients to health care
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providers' recommendations, rather than an active participant in the treatment
process (DiMatteo and DiNicola, 1982). Consequently, the term 'adherence' is now
more frequently applied within the literature and this reflects an important shift in
thinking about the delivery of health care. Rapoff postulates that effective health care
requires a co-operative relationship between patients and providers, where the patient
feels understood and able to discuss treatment difficulties with their provider, since it
is the patient who determines whether or not they will engage in the prescribed
regimen to lessen the impact of an illness.
1.2.2 Prevalence of Non-adherence
The prevalence of non-adherence to treatment regimens appears to vary depending
on the health condition, the age of the patient, the regimen required, the measure of
adherence applied and the criteria used to classify acceptable levels of adherence.
Studies have suggested that non-adherence is particularly problematic in chronic
health conditions. Rapoff and Barnard (1991) estimate that about a third of patients
do not adequately adhere to regimens for acute conditions whilst between 50-55% do
not adhere to regimens for chronic conditions. Conway et al (1996) also claim that
patients with a chronic disease only comply with about 50% of their treatment and
suggest that adherence may be less than optimal since chronic health conditions often
require more complex and time-consuming daily regimens.
Passero, Remor and Salomon (1981) measured adherence to CF treatment regimens
via out-patient self-report. The regimens included antibiotics, vitamins, chest
physiotherapy and diet and Passero et al concluded that whilst 90% of out-patients
were completely adherent to antibiotics and vitamins, only 40% complied fully with
20
INTRODUCTION
chest physiotherapy and 20% followed dietary recommendations. Czajkowski and
Koocher (1987) described an adherence rate of 65% to prescribed treatment
regimens, including chest physiotherapy and medication, in hospitalised adolescents
and young adults with CF, although they also found that adherence varied across
treatment components.
1.2.3 Consequences of Non-adherence
Non-adherence to treatment regimens can have significant consequences for the
health outcomes and quality of life of patients (Brown et al, 1994). Within the CF
population, non-adherence to antibiotic medication is linked to the re-emergence of
infectious diseases that have become resistant to previously effective antibiotic drugs
and could be particularly threatening to the well-being of the individual due to their
reduced immunity. Furthermore, physicians may attribute poor outcome to
inadequate treatment regimens and prescribe additional medication or they may
attribute treatment failures to non-adherence and fail to make necessary changes to
the regimen (Rapoff, 1999). Non-adherence to regimens also has financial
consequences in terms of the money spent on unused medication and the cost of
unnecessary increases in hospital admissions due to the resultant deterioration in
health.
1.2.4 Measures of Adherence
A variety of techniques are available to measure levels of adherence including drug
assays, observations, pill counts, health care provider estimates, patient or parental
reports and health outcomes. There is, however, no ideal measurement of adherence
at present with all available techniques having at least some methodological
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limitations (Rapoff, 1999). The advantages and disadvantages of each of the
aforementioned techniques will now be discussed.
1.2.4.1 Drug Assays
Assays are useful to confirm that medication has been ingested and to determine sub¬
therapeutic, therapeutic and toxic levels of drugs. Drug assays also do not rely on
potentially inaccurate estimates of adherence from patients, parents or health care
providers. However, assays measure adherence over relatively short time intervals
and therefore fail to provide information about the consistency of adherence over
extended periods of time (Rapoff, 1999). Furthermore, drug assays may be affected
by differences in the way drugs are absorbed, metabolised and excreted and results
may therefore be unrelated to adherence. Assays are also expensive and invasive and
are therefore less clinically feasible.
1.2.4.2 Observations
Observations can be used to evaluate patient techniques in performing skills
necessary for adherence, such as insulin administration for CF related diabetes.
Observation methods enable clinicians and researchers to measure the frequency and
duration of particular behaviours and avoid possibly misleading subjective
judgements about adherence behaviours. However, observations do not provide
information on how often or consistently an individual performs particular
behaviours when they are not being observed. There is also the risk that patients may
behave differently if they are aware that they are being observed, for example, they
may be more adherent. Moreover, accessibility to adherence behaviours can be
22
INTRODUCTION
problematic. Observations are also labour-intensive and variations between observers
in recording behaviour over time may be evident.
1.2.4.3 Pill Counts
This measure of adherence involves counting medication at two points in time
separated by, for example, a one-week period. Pill counts can be conducted in
clinical settings or information can be provided by patients or parents. However, pill
counts do not confirm ingestion of the medication and the information obtained does
not provide an indication of variations in drug administration over time, such as
overdosing. Furthermore, some researchers have suggested that pill counts should
not be utilised to measure adherence due to significant evidence that they
overestimate adherence behaviour (Bond and Hussar, 1991).
1.2.4.4 Health Care Provider Estimates
Health care provider estimates involve ratings by physicians or nurses of the degree
to which they perceive their patient to be adherent to particular regimen components,
often through the use of a Likert rating scale. Provider estimates are simple and
inexpensive and thereby feasible to use in clinical settings. Nevertheless, Rapoff
(1999) maintains that although provider estimates are generally accurate in
identifying adherent patients, they may fail to identify non-adherent patients.
1.2.4.5 Patient or Parental Reports
Patient or parental reports of levels of adherence are usually obtained via rating
scales, structured interviews or diary keeping and are convenient, inexpensive and
clinically feasible (Bond and Husser, 1991). Patient or parental estimates can,
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however, be sensitive to social desirability effects, whereby patients or families tell
providers what they believe they want to hear, and reports may therefore tend to
overestimate adherence by minimising non-adherence. In order to reduce the
likelihood of socially desirable responses, Rapoff (1999) states that non-judgemental
questions about adherence should be utilised as they are less likely to create
defensive reactions in the respondent, thereby increasing the likelihood that more
accurate information regarding adherence levels will be provided. Rapoff also reports
that patients or parents are often asked to rate adherence over unspecified time
intervals and comments that their estimates may be subject to recall errors. Rudd
(1993) suggests that the "outer limits" for recall for events is generally less than two
weeks and recommends that estimates of adherence should be obtained within a time
period of less than two weeks. Subjective reports are preferable to parental reports
since parental estimates of adherence are not considered to be as accurate since
parents may not always have access to relevant adherence behaviours, especially
during adolescence, and can therefore only report on what they see thereby possibly
underestimating levels of adherence.
1.2.4.6 Health Outcomes
Physiological outcome measures such as pulmonary function tests in CF are useful in
examining the clinical utility of behaviour changes and determining whether
adherence is sufficiently problematic to require intervention (Dunbar and Agras,
1980). However, Rapoff (1999) states that health outcome measures should not be
used as sole indicators of adherence since physical health is multiply determined.
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The aforementioned measures of adherence differ in terms of cost and feasibility for
use in clinical settings. Patient or parental reports regarding adherence remain the
most direct and practical way of assessing adherence in clinical practice as patients
and their family members have a unique perspective on how a chronic condition and
its treatment affect their lives (Rapoff, 1999). Masek and Jankel (1982) suggest that
the most effective measure of adherence is achieved by combining a variety of
techniques and Rapoff posits that regular measures of adherence should be obtained
to provide a more representative view of actual adherence to treatment regimens. In
addition, Lask (1994) postulates that adherence behaviour should be conceptualised
along a continuum as opposed to individuals being defined as either 'adherent' or
'non-adherent'.
1,2.5 Factors affecting Adherence
It is important to examine predictors of adherence behaviour since any negative
correlates consistently identified in studies can be utilised to develop 'risk profiles'
which health care providers can use to identify those patients likely to present with
difficulties in adherence to regimens (Rapoff, 1999). Attempts can then be made to
modify those predictors related to non-adherence. To date, research has focused on
investigations of specific patient, family and regimen factors that influence non-
adherence and these factors will now be discussed.
1.2.5.1 Patient Factors
Studies by Lorenz, Christensen and Pichert (1985) and Patterson (1985) have found
that boys are less adherent than girls to regimens for diabetes and CF respectively
and Patterson has also suggested that lower socio-economic status is associated with
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non-adherence to treatment regimens within these two medical conditions. The age
of the patient can also significantly affect adherence to treatment regimens with
adherence during adolescence and early adulthood being considerably more
problematic than in younger children and this will be the main focus of this section.
Within CF, parents, especially mothers, often have the major responsibility for the
daily management of their child's condition and studies by Gudas, Koocher and
Wyplj (1991), Bond, Aiken and Somerville (1992) and Patterson (1985) have
reported that adherence to chronic conditions such as CF and diabetes is generally
better in childhood than during adolescence when parents begin to transfer
responsibility for self-care to the adolescent.
Adolescence is renowned as a time of major physical, cognitive, emotional and
social change when the development of a sense of independence and the
establishment of peer relationships becomes increasingly important (Tyrrell, 2001).
Conway (1998) reports that adolescence can be a challenging and turbulent time due
to the confusing and conflicting emotions being experienced. The presence of a
chronic illness such as CF can, however, magnify the normal problems associated
with this age group since adolescents with CF also have to deal with assuming
greater responsibility for their condition and its self-management from their parents
as parental assistance decreases and cope with the transition from paediatric to adult




Adolescence is also regarded as a time of experimentation and risk taking behaviour
and many adolescents commonly reject routines and authority in their search for
independence (Tyrrell, 2001). The implications of teenage rebellion can be serious,
however, if the adolescent has a chronic condition. Adolescents with CF may rebel
against the burden of their treatment and neglect regimen tasks, such as
physiotherapy, due to their time-consuming nature which can conflict with after
school activities. Parental reminders to adhere may also be perceived by the
adolescent as controlling and may enhance their resolve not to adhere. In addition to
resulting in conflict with their parent or health care provider, refusal to conduct CF
treatment programmes can put the adolescent at risk of developing health
complications in later life (Pownceby, 1997). Desmond, Schwenk, Thomas, Beaudry
and Coates (1983) stated that after missing three weeks of physiotherapy a
measurable lung function deterioration can be detected although there may not be an
immediate effect on the individual's health.
The desire for social acceptance by peers at this time can also outweigh the demands
of a self-care regimen (Cameron and Gregor, 1987). Within the school environment,
adolescents may be resistant to undertake aspects of their treatment such as taking
pancreatic enzymes at mealtimes due to their embarrassment at being asked the
purpose of the tablets. Having to take enzymes with every meal and snack can also
emphasise that the individual is different from their peers and consequently
adolescents may decide to take the enzymes in secret or may not take them at all.
Adherence to pancreatic enzymes can therefore become problematic at school.
However, good nutrition is of major importance to the long-term survival of CF
patients (Corey, McLaughlin, Williams and Levison, 1988) and therefore adherence
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to the dietary aspects of the regimen is vital. Unfortunately, the focus on weight and
body image and peer pressure to diet during adolescence can also result in reduced
adherence to these aspects in order to remain at the same weight. The consequences
of weight loss for the health of adolescents with CF can be severe and irreversible
and the development of anorexia nervosa, accompanied by a significant deterioration
in the individual's health, is a real risk.
In relation to young adults with CF, Duncan-Skingle and Pankhurst (2001) reported
that many young adults try to identify with their healthy peers as they move towards
early adulthood and brush aside the reality that they have a progressive life-
threatening illness in order to try to enjoy their life. Shale (1996) states that it is
commonplace for young adults to ignore the signs and symptoms that point to a
deterioration in health which can be problematic particularly since many young
adults with CF die within the second or third decade of their life. Gudas et al (1991)
also found that young adults adhered less to medication and hypothesised that as
their disease becomes more severe with age, the amount of medication required
increases. Consequently, the treatment regimen becomes more intrusive for the
young adults and provides a continuous unwanted reminder of the presence of the
disease.
1,2.5.2 Family Factors
As children approach adolescence, parents and health care professionals are faced
with the difficult task of remaining in a supportive role whilst encouraging the
adolescent to assume greater responsibility for treatment and become more
independent. Adherence has been found to be poorer when there is parental-child
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conflict or ambiguity amongst family members regarding who has primary
responsibility for undertaking the regimen tasks. A lack of parental monitoring and
supervision during adolescence has also been found to contribute to non-adherence
and it is emphasised that adolescents, in particular, require support and assistance
from their family to maintain emotional and physical stability during this
developmental stage (Conway, 1998). Adolescents and young adults are also more
likely to adhere with treatment regimens if they have a close relationship with family
members and friends and come from an organised family life where a routine has
been established to undertake treatment, whilst permitting the individual to lead as
normal a life as possible.
1.2.5.3 Regimen Factors
With regard to regimen factors, Gudas et al (1991) assert that patients who are less
knowledgeable about their condition and its treatment are less adherent to regimens.
Haynes (1979) stated that the complexity of the regimen, the duration and severity of
the illness and the intrusiveness of the treatment regimen were related to poorer
adherence. Families have a finite amount of time, energy and resources to devote to
medical regimens particularly if they are to try to maintain some semblance of a
'normal' family life (Patterson, 1985). As would be expected therefore, Glasgow,
McCaul and Schafer (1986) and Passero et al (1981) have stated that adherence tends
to be lower with more complex regimens such as chest physiotherapy in CF and
dietary regimens for diabetes. The perceived benefit of the regimen tasks has also
been associated with inconsistent adherence. D'Angelo and Lask (2001) report that
adherence in CF is better when the regimen task is considered to have an immediate
effect on the health of the individual, for example, severe abdominal pain if
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pancreatic enzyme replacements are not consumed with every meal and snack.
Treatments such as physiotherapy are often perceived by patients and their families
as not having any immediate benefits and may therefore not be regularly undertaken.
Physiotherapy in particular is also time-consuming and impinges on daily activities
(Pownceby, 1997). It is therefore important to provide information on the efficacy of
regimens to demonstrate that patients and their family members' efforts to maintain
optimal adherence are having the desired beneficial effect. Furthermore, since
variations in adherence to different components of treatment have been reported,
Passero et al (1981) state that it is important to consider all aspects of regimen tasks
equally when assessing adherence behaviour.
1.2.6 Summary
Non-adherence to treatment regimens is a commonly acknowledged problem in
health care settings in both adolescents and young adults with CF and reasons for
non-adherence appear to be multiply-determined. There are significant consequences
for the health outcomes of patients who do not adhere and Rapoff (1999) posits that
efforts to change adherence behaviour should be considered when non-adherence is
evidently compromising the health and well-being of the patient. In view of the
significant problems with non-adherence reported within young people with CF it is
considered an important area for studies to investigate with the aim of developing
strategies to encourage improved adherence. The impact of psychological problems
on adherence will be discussed within the next section of this chapter and the
influence of the practitioner-patient interaction on adherence to treatment regimens
will be discussed in section 1.4.
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1.3 PSYCHOLOGICAL PROBLEMS IN CHRONIC CONDITIONS
1.3.1 Prevalence of Psychological Problems in Cystic Fibrosis
Research has been undertaken to examine the prevalence of psychological problems
within chronic conditions. Cappeli et al (1987) reported that living with a chronic
disease can be a considerable source of stress for children and adolescents due to the
limitations to their freedom. Furthermore, Kyngas and Barlow (1995) interviewed 51
adolescents aged between 13 and 17 years with insulin dependent diabetes mellitus
to determine the impact of diabetes on their lives. The results suggested that diabetes
had an effect on the psychological well-being of participants and was associated with
fear, depression, worry, stress and guilt. In particular, participants presented with
anxiety about their ability to cope with possible future complications and depression
about the limitations imposed by the need for regular, life long insulin treatment.
Feelings of guilt were also reported if the participant had been neglecting their self-
care. Kyngas and Barlow concluded that having a chronic disease was perceived by
the adolescents as a threat to their psychological, social and physical well-being.
Within the CF population, early research also suggested a high incidence of
emotional disturbance, particularly depression, in children (Lawler, Nakielny and
Wright, 1996). In addition, Aspin (1991) reported that CF patients were prone to
develop symptoms of anxiety or depression as they had little sense of control over
their illness and Thompson, Hodges and Hamlett (1990) reported a high incidence of
anxiety. Cowen et al (1984) also investigated the prevalence of psychological
distress in 191 CF patients aged 16 years and above and found that participants
presented with significant levels of psychological distress. In particular, the results
suggested that 12% of males and 30% of females with CF aged between 16 and 19
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years displayed moderate or severe levels of emotional distress whilst the frequency
of distress doubled in both males and females over the age of 20 years. Moreover,
Strauss and Wellisch (1981) reported that 43% of their sample of adult CF patients
reported feeling depressed 'occasionally' or 'frequently' and claimed that this was
due to their concerns regarding their physical appearance, the constant treatments
required for the condition and uncertainty about their future health. Adults with CF
are required to undertake similar treatments to adolescents in order to maintain body
weight, nutrition and lung function (Shale, 1996). However, adults also have to deal
with additional issues such as the development of liver disease and diabetes, male
infertility, concerns regarding pregnancy, issues relating to career prospects and
independent living and the prospect of limited survival. These additional factors may
account for the reports of increased psychological problems within this age group.
Nevertheless, despite studies suggesting high rates of psychological distress within
the CF population, Angst (2001) reports that more recent research has not
demonstrated a difference in the prevalence of emotional problems in CF patients
when compared with healthy controls and has in fact pointed to the resilience and
adaptability of these patients to their condition. Blair, Cull and Freeman (1994)
found that adolescents and young adults with CF were indistinguishable from healthy
controls in terms of emotional disturbance and Gee et al (1996) backed this finding
with their survey of 90 adults with CF and 106 healthy controls. Gee et al reported
that there was no difference in anxiety and depression between the groups although
they commented that borderline anxiety was common in both groups as identified on
the Hospital Anxiety and Depression Scale. Gee and colleagues also spoke of the
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importance of differentiating between specific psychological disorders as opposed to
classifying psychological distress as inclusive of both anxiety and depression.
1.3.2 The Influence of Psychological Problems on Adherence
Few studies have investigated the effect of psychological distress on adherence to
self-management regimens in chronic conditions, particularly CF. Rapoff (1991)
postulates that non-adherence may result from or exist concurrently with emotional
problems. Within diabetes literature, research by Kovacs, Goldston, Obrosky and
Iyengar (1992) and Jacobson et al (1987) have shown that patients with behavioural
or emotional problems are less likely to adhere to diabetic regimens. In the CF
population, Gudas et al (1991) reported that greater pessimism and low mood was
associated with non-adherence to CF treatment regimens. Furthermore, Koocher,
McGrath and Gudas (1990) interviewed 223 patients with CF and their family
members and reported that the presence of depression and anxiety interfered with
adherence. Both Hains, Davies, Behrens and Biller (1997) and Mullins, Pace and
Keller (1994) postulate that cognitive behaviour therapy may be effective to resolve
psychological issues, particularly anxiety and depression, in individuals with chronic
conditions and consequently improve their adherence to treatment regimens.
1.3.3 Summary
Differences are apparent in reports of the prevalence of psychological distress within
the CF population. Whilst some studies claim that there is a high incidence of anxiety
and depression in CF patients compared with healthy controls, other studies suggest
that there are no differences. Psychological distress has, however, been reported to
have a negative impact on adherence to treatment regimens in CF and diabetes
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patients. It would therefore seem important that psychological input is available
within CF teams in order to resolve these emotional difficulties and reduce their
deleterious effect on self-management behaviours.
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1.4 SELF-DETERMINATION THEORY OF HUMAN MOTIVATION
1.4.1 Introduction to Self-determination Theory
The Self-determination Theory of Human Motivation, developed by Deci and Ryan
(1985), provides a theoretical basis for explaining human motivation to undertake a
variety of health related behaviours. The theory maintains that an understanding of
motivation to behave requires a consideration of innate psychological needs for
competence and autonomy which, when satisfied, enhance self-motivation and well-
being and, when thwarted, result in diminished motivation.
1.4.2 Autonomous versus Controlled Professional Relationship Styles
Within a health care setting, self-determination theory emphasises the importance of
an 'autonomy supportive' interpersonal climate where a person in a position of
authority, for example a physician, takes the perspective of another into account,
acknowledges their feelings, solicits their opinions, encourages questions and
provides relevant information and opportunities for choice. An autonomy supportive
interpersonal style is considered to be closely related to 'patient centredness', a term
devised by Laine and Davidoff (1996). Within the health care literature, the terms
autonomy and independence have often been used interchangeably but Deci and
Ryan (1985) state that autonomous support does not necessarily mean being
permissive and giving patients the freedom to make their own medical decisions with
little or no advice from professionals. Instead it describes a partnership where the
patient in engaged in the discussion, feels their perspective is understood and is
provided with information and options about treatment without pressure. In contrast,
a controlling style involves pressurising others to behave in particular ways whilst
taking little account of their perspective and is considered to be more authoritarian.
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The Health Care Climate Questionnaire has been developed by Williams, Freedman
and Deci (1998a) to measure patients' perceptions of their health care provider as
being autonomy supportive versus controlling whilst discussing self-management
behaviours.
1.4.3 Autonomous versus Controlled Motivation
Self-determination theory also distinguishes between different types of motivation.
Williams, Saizow and Ryan (1999) report that motivation refers to forces that move
people to act. They postulate that some theories of motivation focus exclusively on
levels of motivation and state that researchers who think of motivation in this way
have tended to examine conditions that result in high levels of motivation versus
conditions that result in little or no motivation. However, Williams et al emphasise
the importance of differentiating between types of motivation as opposed to simply
defining levels of motivation, as they claim that different types of motivation, even
when the resulting motivation is high, will lead to very different outcomes. The self-
determination theory differentiates between motivation that is 'autonomous' or
'controlled'. Autonomous motivation to behave reflects what people find important
and involves a sense of volition and choice over their behaviour whereas controlled
motivation depends on explicit or implicit rewards or punishments or people's
internalised beliefs about what is expected of them. Controlled motivation also
involves the extent to which an individual feels coerced or pressurised to behave or
comply in a particular manner. Self-determination theory proposes that behaviour
change will occur and persist if it is autonomously motivated in a relevant social
context of autonomy supportiveness (Williams, Grow, Freedman, Ryan and Deci,
1996). The Treatment Self-regulation Questionnaire was developed by Ryan and
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Connell (1989) to assess the degree to which an individual's motivation for a
particular behaviour is autonomous or due to the controlling influence of another.
1.4.4 Self-efficacy
Perceived self-efficacy is a central construct of the Social Cognitive Theory of
Human Behaviour (Bandura, 1986). The term describes an individual's belief in
their ability to organise and execute the courses of action required in any given task.
Rapoff (1999) states that with regard to adherence behaviours to medical regimens,
competent functioning requires both skills and self-beliefs of efficacy to use the
skills effectively. Rapoff claims that children and adolescents who have the
necessary skills and have strong beliefs in their capabilities to perform adherence
tasks are more likely to approach difficult regimen tasks as 'challenges' to be
mastered rather than 'threats'. Furthermore, they are more likely to set health
enhancing goals for themselves and be strongly committed to these goals and
increase and sustain their efforts to achieve their goals even when faced with
setbacks. Bandura states that perceived self-efficacy is the most powerful
determinant of behaviour and O'Leary (1992) postulates that self-efficacy has an
influential effect on adherence behaviours, stating that individuals high in self-
efficacy are more likely to adhere to medical regimens and thereby improve or
maintain their health. Studies undertaken to investigate the influence of self-efficacy
on adherence in chronic health conditions have repeatedly demonstrated that self-
efficacy is a significant predictor of self-management behaviour.
Within the CF population, Bartholomew, Parcel, Swank and Czyzewski (1993)
examined the influence of the self-efficacy of children with CF and their families on
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self-management behaviours and concluded that when self-efficacy was enhanced,
improvements in the self-management of CF and subsequent health care outcomes
was evident. In addition. Parcel et al (1994) reported that self-efficacy was the most
important factor in predicting the initiation and continuation of self-management
behaviour in CF patients. They stated that interventions that focused on increasing
knowledge alone were less effective in improving self-management behaviours in CF
patients and their families than interventions that addressed self-efficacy. Williams,
Rodin, Ryan, Grolnick and Deci (1998b) posit that self-efficacy is similar to the
concept of perceived competence described in the self-determination theory of
human motivation and claim that self-efficacy can be enhanced within the context of
an autonomy supportive relationship where a health care provider conveys
confidence in the individual's ability to achieve negotiated goals. The Self-efficacy
Questionnaire was developed by Williams, Freedman and Deci (1998a) to measure
an individual's perceived competence in their ability to undertake self-management
tasks.
1.4.5 Previous Research Applying Self-determination Theory
Self-determination theory posits that the interpersonal style of significant others will
engender different types of motivation. Health care studies guided by the self-
determination theory have demonstrated that when health care providers are
autonomy supportive, patients are encouraged to develop and maintain more
autonomous motivation regarding their health care. Furthermore, patients feel more
competent in carrying out a variety of health related behaviours resulting in increased
adherence to treatment regimens and improved health outcomes (Deci, Eghrari,
Patrick and Leone, 1994). Similar findings have been found in relation to HbA(lc)
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reduction for patients with diabetes (Williams et al, 1998a), medication adherence in
adult out-patients (Williams et al, 1998b), maintained weight loss in morbidly obese
patients (Williams et al, 1996), smoking cessation (Williams and Deci, 1996) and
asthma self-management (Howells, Greene, Neville, Pagliari, Mukhopadhyay,
Alexander and Greene, 2001).
Williams et al (1998a) investigated whether patients who perceived their health care
providers as autonomy supportive would display an increase in autonomous
motivation and perceived competence, leading to improved glucose control over a
twelve-month study period. 128 individuals between the ages of 18 and 80 years
participated in the study and Williams and colleagues found that patients' perception
of autonomy support from their health care provider predicted a significance increase
in patients' autonomous motivation to regulate their glucose levels. Furthermore,
they reported that this increase in autonomous motivation was related to a significant
increase in perceived competence in ability to regulate glucose which was in turn
related to significant reductions in the HbA(lc) values over twelve months (See
Figure 1). Williams et al concluded that attention to psycho-social factors within
patient care was as important as consideration to biological contributions to illness
since psycho-social factors appeared to significantly influence patients' physical
health outcome.
Figure 1: The self-determination model (Williams et al, 1998a)
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Williams et al (1998b) also applied the self-determination theory to explore the
motivational basis of adherence to long-term medication prescriptions. Participants
with various diagnoses who had been taking medication for at least one month
completed questionnaires to assess their motivation to adhere and their perceptions of
their physicians' interpersonal style. Participants gave subjective ratings of their
adherence and a two-day retrospective and a 14-day prospective pill count was
undertaken. The results demonstrated that when physicians were perceived by their
patients as autonomy supportive, the patients reported greater autonomous
motivation for taking their medication and better adherence to prescribed regimens
thereby providing further support for the self-determination model. Although
Williams et al highlighted the possibility that patient perceptions rather than
providers' behaviour were the determining variables, the study was consistent with
the hypothesis that autonomy supportiveness on the part of the physician influenced
patient behaviour and subsequent health outcomes.
An earlier study by Williams and colleagues (1996) involved 128 morbidly obese
patients in a six-month weight loss programme with a 23 month follow up. Patients
were asked to rate the health care team as either autonomy supportive or controlling
using the Health Care Climate Questionnaire. Williams et al reported that patients
who perceived an autonomy supportive interpersonal climate created by the health
care staff displayed greater autonomous motivation for weight loss, attended the six-
month program more regularly, lost more weight during the program and maintained
greater weight loss at follow up than those who perceived the health care team as
more controlling. The results of the study demonstrated further support for the self-
determination theory. Furthermore, Williams and Deci (1996) conducted a
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longitudinal study on smoking cessation and the results suggested that physicians
perceived by their patient as autonomy supportive significantly enhanced the
autonomous motivation and perceived competence of smokers for not smoking
which was related to better cessation over a six-month period. Williams and Deci
asserted that the use of an autonomous interpersonal style significantly enhanced
smokers' motivation to behave in healthier ways.
In addition, Howells et al (2001) used the self-determination theory to guide their
study of 67 young people with asthma, aged between 13 and 22 years. Participants
completed the Health Care Climate Questionnaire, Treatment Self-Regulation
Questionnaire, Self-efficacy Questionnaire and an Asthma General Knowledge
Questionnaire in addition to providing a self-report measure of adherence. The
results emphasised the importance of autonomy supportive health care providers and
autonomous motivation on improving adherence to asthma self-management with
self-efficacy as a potential mediating variable.
1.4.6 Summary
Research on the application of self-determination theory to chronic health conditions
is in its early stages, however, results to date have supported the use of the model
within health care settings. Consequently, Williams and Deci (2001) posit that
physicians should be encouraged to be more autonomy supportive in their
interactions with patients since this specific interpersonal style has been associated
with more effective health care delivery and more positive health outcomes.
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1.5 PRESENT STUDY: AIMS AND HYPOTHESES
1.5.1 Aims
The current study uses the Self-Determination Theory of Human Motivation (Deci
and Ryan, 1985) to guide an investigation into factors that promote adherence to CF
treatment regimens in adolescents and young adults. The theory highlights the role of
autonomy supportive health care provider relationship styles in increasing patients'
self-efficacy and motivation for self-management and the present study aims to
replicate the findings of previous research in individuals with CF. The study also
aims to examine the role of emotional well-being on adherence. As few studies
within the CF literature have drawn upon both quantitative and qualitative data, a
novel aspect of this research was to obtain detailed information on the personal
experiences of young people with CF by using an interview format. In particular,
information was gathered regarding the impact of the condition on their lives,
reasons for adherence to regimens and particular professional relationship styles
associated with good CF self-management. The results of the current study would be
expected to provide information regarding factors influential in maximising
adherence behaviours that can be presented to health care providers within CF teams
to enable them to offer optimal support to young people with CF. The hypotheses are
divided into two sections that include predictions from previous research findings




On the basis ofprevious findings from the literature it is predicted that:
1(a) Autonomy supportive relationships between health care providers and
adolescents and young adults with CF will be associated with greater
autonomous motivation to adhere.
1 (b) Autonomy supportive relationships between health care providers and
adolescents and young adults with CF will be associated with greater self-
efficacy.
1(c) Autonomous motivation to adhere will be associated with greater self-
efficacy.
1(d) Adolescents and young adults who report greater self-efficacy will display
increased adherence to CF treatment regimens.
2 Lower levels of psychological distress (anxiety and depression) will be
reported by adolescents and young adults with CF who perceive their health
care providers as autonomy supportive.
3 Adolescents and young adults with CF who report greater self-efficacy will
display lower levels of psychological distress (anxiety and depression).
Experimental hypotheses:
4 Higher levels of psychological distress (anxiety and depression) in
adolescents and young adults with CF will be associated with poorer
adherence to CF treatment regimens.
5 Increased age will be associated with better adherence to CF treatment
regimens.
6 Increased severity of CF will be associated with increased psychological







A cross-sectional, investigative study was undertaken with adolescents and young
adults attending out-patient CF clinics in Tayside. A pack consisting of five self-
report measures was sent to potential participants by post. These measures examined
perceived health care provider relationship styles, self-efficacy, motivation to follow
a treatment regimen, emotional well-being and adherence behaviour. In addition,
semi-structured interviews were carried out with a sub-set of participants to provide
qualitative data to augment the quantitative data obtained from the questionnaires.
2.2 PARTICIPANTS
The participants included adolescents and young adults with CF, aged between 12
and 26 years, who attended the out-patient paediatric and adult CF clinics in Tayside.
A wide age range was chosen so that any developmental trends could be identified.
Within the CF literature there is no consistent classification by which to define
adolescents and young adults. In the current study, participants aged between 12-18
years were classified as 'adolescents' whilst participants aged between 19-26 years
were classified as 'young adults'. These classifications were applied in line with
studies by Angst (2001), Christian and D'Auria (1997) and Duncan-Skingle and
Pankhurst (2001) who defined school-aged children as between 7-11 years,
adolescents as aged between 12-18 years and young adults as 19 years and upwards
respectively. Furthermore, in an attempt to ensure a similar range of ages within each
classification, the cut off for young adults was set at 26 years of age.
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The criteriafor inclusion in the study were:
■ Adolescents and young adults with CF aged between 12-26 years
■ Current attendance at the CF out-patient clinics in Tayside
The criteriafor exclusion in the study were:
■ Any individual with CF currently attending psychiatric services
■ The presence of another major medical condition
Fifty-three individuals who attended the Tayside CF clinics were invited to
participate in the study, 13 adolescents and 40 young adults. Thirty-six individuals
did not return the consent forms or questionnaire measures and four individuals
contacted the researcher to report that they did not wish to participate in the study as
they were undertaking examinations at school. Thirteen individuals agreed to
participate in the study. Nine participants completed the questionnaire measures and
agreed to be interviewed, although one individual did not attend the appointment for
the interview, and four individuals completed the questionnaires only.
Due to the low response rate, the geographical area for recruitment was expanded
and additional participants from the Forth Valley CF clinics were invited to
participate in the study. An explanation of the steps undertaken in order to do this is
presented within the procedure section. Seven individuals, three adolescents and four
young adults, were selected and two individuals returned the completed
questionnaire pack, bringing the total number of participants to fifteen. Following
discussions with the consultants in the Tayside and Forth Valley CF clinics regarding
the response rate, the age range of participants was increased to 30 years. Seven
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additional individuals met the criteria for inclusion, five in Tayside and two in Forth
Valley, bringing the total number of individuals invited to participate in the study to
67. No further responses were returned however.
2.3 MEASURES
The measures employed in the current study are summarised in Table 1 and will be
discussed in turn. The questionnaire pack containing these measures can be seen in
Appendix 1.
Table 1: Measures used in the current study
VARIABLE MEASURED MEASURE REFERENCE
Health care provider
relationship style
The Health Care Climate
Questionnaire









Ryan & Connell (1989)
Emotional well-being The Hospital Anxiety and
Depression Scale
Zigmond & Snaith (1983)








2.3.1 The Health Care Climate Questionnaire (HCCQ)
The HCCQ was developed by Williams and Deci (1996) to measure patients'
perceptions of their health care providers as being 'autonomy supportive' versus
'controlling' in their behaviour towards the patient whilst discussing self-
management. The HCCQ consists of fifteen items and responses are measured by a
seven-point Likert rating scale ranging from 1 = 'strongly disagree' to 7 = 'strongly
agree'. A total score is obtained and the higher the score, the greater the respondent's
perception of the health care provider having an 'autonomy supportive' interpersonal
style. In the present study the health care providers were represented by the
consultant or nurse within the CF clinics. Respondents were notified that they were
to answer in terms of their overall perspective of both health care providers.
The HCCQ has been used and validated in studies of weight loss (Williams et al,
1996) and smoking cessation (Williams and Deci, 1996) and internal consistency has
been shown to be high with Cronbach a values of 0.92 and 0.96 respectively.
Furthermore, Williams and Deci report that patients' perceptions of health care
providers are reasonably stable over time with 6-8 month correlations of
approximately r = 0.6. Although the HCCQ has not been standardised for use with
adolescents, Howells et al (2001) modified the layout of the items and response
format for use with adolescents with asthma and reported that the items were easily
understood and completed by patients. The HCCQ was considered to be appropriate
for the current study and permission was obtained from the authors to use the
questionnaire. Permission was also obtained from Howells et al to utilise the
modified layout and the language was adapted to reflect local CF self-management
terminology. A Cronbach a value of 0.83 was obtained in the current study.
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2.3.2 The Self-efficacy Questionnaire (SEQ)
This four-item measure was designed by Williams et al (1998a) to assess a person's
perceived competence to undertake specific self-management tasks. Responses are
scored on a seven-point Likert rating scale ranging from 1 = 'strongly disagree' to
7 = 'strongly agree'. The scale has been used in previous studies involving diabetic
and asthmatic patients with good internal consistency as Cronbach a values of 0.80
and 0.94 demonstrate. In the present study the questionnaire was modified with the
authors' permission so that it was appropriate for the CF population and a Cronbach
a value of 0.88 was obtained.
2.3.3 The Treatment Self-regulation Questionnaire (TSRQ)
The TSRQ was developed by Ryan and Connell (1989) to measure the reasons why
people would engage in healthy behaviours, try to change unhealthy behaviours or
follow a treatment regimen. The questionnaire assesses the degree to which an
individual's motivation for a particular behaviour is autonomous or due to the
controlling influence of others, for example, professional carers. The TSRQ is a 13-
item measure and respondents rate the degree to which they agree with the items
using a seven-point Likert rating scale ranging from 1 = 'strongly disagree' to 7 =
'strongly agree'. Two factors are identified within the measure: Autonomous
motivating factors and controlling carers' motivating factors. Questions
2,3,5,7,9,10,11,13 are included within the autonomous motivating factors subscale
whilst questions 1,4,6,8,12 make up the controlling carers' motivating factors
subscale. An example of an autonomous motivation item is: "I believe that tightly
controlling my CF will greatly improve my health" whilst an example of a controlled
reason is: "Other people would be mad at me if I didn't".
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According to Ryan and Connell the questionnaire has good internal consistency with
a Cronbach a value of 0.87 and past research by Williams et al (1996) and Williams
et al (1998a) support the construct validity of this measure. In the present study the
questionnaire was modified with the authors' permission to include local CF self-
management terminology and Cronbach a values of 0.73 and 0.89 were obtained for
the autonomous and controlled motivation subscales respectively.
2.3.4 The Hospital Anxiety and Depression Scale (HADS)
The HADS was developed by Zigmond and Snaith in 1983 for use in medical out¬
patient clinics to detect clinical levels of anxiety and depression, independent of
physical symptomatology. The scale consists of 14 items and levels of anxiety and
depression are measured on two separate subscales containing seven items each. The
respondent is required to rate each item on a four-point rating scale, scored from 0 to
3, so that the total score for each subscale ranges from 0 to 21. The HADS can also
be utilised to gauge the severity of anxiety and depression and includes four
classifications for score ranges: Normal (0-7), Mild (8-10), Moderate (11-14) and
Severe (15-21). A score of 11 or more represents clinical 'caseness' for anxiety or
depression.
The reliability and validity of the HADS has been established in studies of medical
out-patients (Zigmond and Snaith, 1983) and patients with cancer (Moorey et al,
1991). Zigmond and Snaith report that the HADS demonstrates a high rate of internal
consistency with Cronbach a values of 0.93 for the anxiety subscale and 0.9 for the
depression subscale. The above studies suggest good psychometric properties based
on specific populations such as medical out-patients. The HADS was therefore
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considered appropriate to utilise in the current study to detect levels of psychological
distress independent of CF symptoms and Cronbach a values of 0.77 and 0.71 were
obtained for the anxiety and depression subscales respectively.
2.3.5 Self-report Measure of Adherence
A self-report estimate of adherence was obtained from participants. The measure was
developed by Howells et al (2001) for use with asthma patients and was modified for
use with CF patients in the current study. Bond and Hussar (1991) assert that patient
reports of adherence behaviours are relatively simple and convenient to obtain and
Rapoff (1999) states that patient reports address the problem of accessibility to
patient behaviours over time and enable estimates to be obtained in ecologically
relevant contexts such as the patients' home. Participants were required to estimate
their level of adherence to four aspects of CF treatment regimens: Medication
(antibiotics), physiotherapy, diet (pancreatic enzymes and vitamin supplements) and
exercise. Estimates of adherence were obtained over a one-week period using a five-
point Likert rating scale ranging from 0 = 'never/frequently miss days' to 4 = 'every
day'. A higher score indicated relative adherence whilst a lower score indicated
relative non-adherence. The specified time frame was applied in order to minimise
recall errors since Rudd (1993) states that recall for events is generally less than two
weeks. Respondents were also asked to comment on whether the previous week had
been a 'typical' week to determine whether their estimate of adherence could be
considered to be representative of their general adherence to their treatment regimen.
METHOD
2.3.6 Semi-structured Interview
A semi-structured interview was undertaken to explore the personal experiences of
participants on a range of topics that related to the hypotheses of the study. The
topics covered during the interview included the impact of CF on the individual's
lifestyle, issues relating to adherence or non-adherence to the treatment regimen,
emotional well-being and experiences of health care providers' relationship styles.
An interview schedule was developed to ensure that all interviews followed a similar
outline although the format was flexible to allow the researcher to adapt it depending
on the participant's experiences of CF. Participants were also permitted to discuss
any issues that had arisen from the completion of the questionnaire measures. Sample





- Age at diagnosis
Emotional Well-being
- Feelings about having CF
- Effect of having CF whilst growing up
- Support network
Information Regarding Treatment Regimen
- Treatment regimen required
- Confidence in managing treatment regimen
- Regimen tasks considered the easiest and most difficult to adhere to
- Possible reasons for non-adherence
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Relationships with Health Care Providers
- Relationships with health care providers (both positive and negative experiences)
- Satisfaction with the delivery of services
Future Issues
- Worries or concerns about the future/Future health
2.3.7 Other Information Collected
The questionnaire pack issued to participants requested information on age, gender
and the health care provider seen most often within the CF clinic. A general
information sheet was also developed for the study to record demographic data on
age at diagnosis, prescribed treatment regimen, occupation, who the participant lived
with and their postcode sector to calculate the corresponding social deprivation
category (Carstairs and Morris, 1991). The demographic information was obtained
from participants' hospital case notes and the information sheet can be seen in
Appendix 3. In addition, an objective measure of physical functioning (FEV1 %
predicted) was gathered from the hospital case notes. Lung function, as mentioned
earlier, is commonly measured by forced expiratory volume at one second (FEV1)
and CF patients are assigned a predicted FEV1 value based on their gender, age and
height. The FEV1 % predicted gives an indication of the capacity to which an
individual is functioning, for example at 70% of their predicted FEV1. Since lung
function can deteriorate with infections, a higher FEV1 indicates a stable period of
health (Ramsey and Marshall, 1995). FEV1 % predicted is commonly used in
clinical and research settings as a measure of severity of illness and in the current
study an average FEV1 % predicted value was calculated for each participant from




Participants were initially recruited from patients currently attending the paediatric
and adult CF out-patient clinics in a large teaching hospital in Tayside. The
researcher met with the consultant paediatricians, the consultant respiratory
physicians and the CF liaison nurses to discuss the nature of the study and gain their
approval to proceed. Ethical approval was then sought and obtained from the Tayside
Committee on Medical Research Ethics. No changes to the research design were
required but minor changes were requested for the participants' introductory letter
and information sheet. A detailed account of the time delay incurred whilst awaiting
ethical approval from the research ethics committee is presented within the
discussion section. Caldicott Guardian approval to access participants' hospital case
notes was also obtained from the Medical Directors within Tayside NHS Health
Board and thereafter, suitable participants were identified by the consultants. To
maintain confidentiality the researcher was not permitted to access patient details
until the individuals had consented to participate in the study. The CF liaison nurses
therefore agreed to send out by post the introductory letter, information sheet
detailing the study, consent form and questionnaire pack to the selected individuals
(See Appendices 4,5,6 and 1 respectively). A reply slip was also enclosed for
completion by individuals who were willing to attend the semi-structured interview
(See Appendix 7).
Individuals were encouraged to contact the researcher if they had any questions
about the study or required further information prior to giving informed consent.
They were asked to decide whether or not to participate in the study within a
fortnight and to return the completed questionnaire pack in the self-addressed
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envelope provided. Individuals were informed that their decision to participate in the
research was entirely voluntary and would not affect their treatment if they chose to
withdraw from the study at any time. Confidentiality of responses was assured
although the information sheet specified circumstances when information would be
fed-back to the consultants with the participant's consent, for example, if any
participant appeared to be exhibiting significant emotional distress from their
answers to the HADS with a score of 11+ on either subscale. Individuals were also
notified that their GP would be informed of their participation in the study (See
Appendix 8 for letter sent to GPs). Additional parental consent was sought for those
individuals under 16 years of age and an introductory letter and information sheet for
parents was enclosed with the correspondence (See Appendices 9 and 10). Three
weeks after the initial correspondence was issued, a reminder letter was sent to all
participants or their parent/guardian to encourage the return of further consent forms
and completed questionnaire packs and this letter is included in Appendix 11.
Due to the low response rate, the researcher contacted the consultant respiratory
physicians in two hospitals in Forth Valley to discuss the study. Thereafter, a
proposal was submitted to the Forth Valley Ethics of Research Committee and
following minor changes, approval was granted for the study to be undertaken.
Caldicott Guardian approval to access participants' hospital case notes was also
obtained from the Medical Director of Forth Valley NHS Health Board. The CF
liaison nurses agreed to send out the introductory letter, information sheet, consent
form and questionnaire pack, shown in Appendices 4,5,6 and 1 respectively, to those
individuals considered suitable for inclusion by the consultants. A reminder letter
was also sent out three weeks after the initial correspondence to elicit further
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responses (See Appendix 11). Following additional discussions with the consultants
within the Tayside and Forth Valley CF clinics regarding the response rate, it was
decided that the age range of participants would be increased to 30 years and the
Tayside Committee on Medical Research Ethics and Forth Valley Ethics of Research
Committee were notified of and approved this amendment.
Having received the completed questionnaire measures the researcher telephoned
those participants who had agreed to be interviewed in order to arrange a convenient
appointment. All interviews were conducted by the researcher within the
participants' homes and lasted between 40 minutes to an hour. Where possible, the
interviews were undertaken within two weeks of receiving the completed
questionnaire packs from each participant. All interviews were tape recorded with
participants' consent and were fully transcribed afterwards. So as not to influence the
course of the interview, the researcher reviewed participants' hospital case notes to
collect the required demographic details after completing the interview.
2.5 ANALYSIS OF DATA
2.5.1 Data Analysis
The data was analysed using the Statistical Package for Social Sciences (SPSS) for
Windows 2000, PC-version 10.0. All variables were checked for assumptions of
normality by examining frequency distribution charts and appropriate statistical tests
were selected accordingly. Descriptive statistics and an Independent t-test were
employed on the demographic data and relationships between variables were
calculated using parametric bivariate correlations (Pearson r correlation co-efficient)
and partial correlations. A larger sample size would have allowed for multiple
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regression analysis to examine potential predictors of adherence to CF self-
management.
A thematic analysis of the interview data was undertaken to explore the impact of CF
on the participants' lifestyle, issues affecting adherence to treatment regimens and
experiences of health care providers' interpersonal styles. Repeated readings of the
transcripts were undertaken to identify themes and patterns of responses. Current
literature examining adherence to treatment regimens in chronic health conditions,
the influence of health care professional relationship styles on adherence and
emotional well-being in chronic conditions was also consulted to facilitate the
development of themes for the analysis.
2.5.2 Statistical Power
Following discussions with the consultant paediatricians and consultant respiratory
physicians in Tayside it was expected that approximately 60 patients would meet the
inclusion criteria for the study. In view of results from a similar study by Howells et
al (2001) within the asthma population, a large effect size was anticipated. A power
calculation indicated that at least 40 participants would be required in order to
achieve sufficient statistical power to detect a large effect size at the 0.8 level
(Cohen, 1992). Fewer participants were recruited than was initially anticipated,
however, and possible reasons for the low response rate are identified within the








3.1.1 Exploration of the Data
The data was explored prior to statistical analysis to check for normality and those
variables showing significant skewness or kurtosis were transformed. The only
variable found to depart from normality was age at diagnosis which was positively
skewed. A logarithm (to the base 10) transformation was therefore applied so that the
values of the variable more closely matched the normal distribution thereby
satisfying the distribution requirements for the use of parametric statistics.
Throughout this section, significant results are reported at the p<0.05 level, or p<0.01
where applicable, and all significant results are reported in bold type.
3.1.2 Participants
Sixty-seven individuals were invited to participate in the study. Fifty-eight
individuals were selected from the Tayside CF clinics with nine individuals selected
from the Forth Valley CF clinics. Forty-eight individuals (71.6%) did not return the
consent forms or questionnaire measures and four individuals (6%) contacted the
researcher to report that they did not wish to participate in the study as they were
undertaking examinations at school. Fifteen individuals, seven males and eight
females, were included in the study, giving a response rate of 22.4%. Nine
participants completed the questionnaire measures and agreed to be interviewed,
although one individual did not attend the appointment for the interview, and six
individuals consented to complete the questionnaires only. A summary of the number
of patients approached and recruited from the CF clinics within Tayside and Forth
Valley Health Board is shown in Table 2.
59
RESULTS
Table 2: Summary of patients approached and recruited (n=67)
TAYSIDE FORTH VALLEY
Eligible participants approached 58 9
Completed questionnaires only 5 (8.6%) 2 (22.2%)
Completed both questionnaires 8 (13.8%) 0
and interview
Declined to participate 4 (6.9%) 0
Did not respond 41 (70.7%) 7 (77.8%)
3.1.3 Summary of Demographic Data
On examination the two respondents from the Forth Valley CF clinics did not appear
to differ from the Tayside sample on any of the demographic variables (See
Appendix 12 for graphs of participants' demographic details). It was therefore
considered appropriate to combine all participants' responses during the data
analysis. A summary of demographic details of participants from the CF clinics
within Tayside and Forth Valley Health Boards is given in Table 3. The table
includes gender, age (in years), age at diagnosis (in months), severity of illness and
social deprivation category (Depcat). Participants' postcode sectors were used to
calculate the corresponding social deprivation category ranging from Depcat 1 and




Table 3: Demographic details of participants (n=15)
Participants from Tayside and Forth Valley
Variable N Mean SD Min. Max.
Female 8
Male 7
Age (in years) 16.73 4.56 12 26
Age at diagnosis 16.13 30.61 1 120
(in months)
Severity of illness 77.33 13.96 52 99
(FEV1% predicted)
Social deprivation 3.60 1.35 2 6
category
(Depcat 1-7)
Non-respondents: In order to maintain confidentiality, the Medical Directors within
Tayside and Forth Valley NHS Health Boards granted Caldicott Guardian approval
to access participants' hospital case notes on the understanding that the case notes
would not be accessed unless consent to participate in the study had been received. It
was therefore not possible to gather any demographic information about non-
responders in order to assess whether the responses obtained were representative of
the CF population as a whole.
Age: The frequency distribution of ages of participants is shown in Figure 2. Nine
participants (60%) were classified as adolescents (12-18 years) and six participants
(40%) were classified as young adults (19-26 years).
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Age at diagnosis: With regard to age at diagnosis, eleven participants (73.3%) were
diagnosed with CF within the first six months following birth. Two participants
(13.3%) were diagnosed by two years of age, one participant (6.7%) was diagnosed
at three years of age and the remaining participant (6.7%) was not diagnosed until ten
years of age.
Social Deprivation Category: The frequency distribution of social deprivation
categories for all participants is illustrated in Figure 3. Three participants (20%)
came from Depcat 2. The majority of participants came from Depcat 3 and 4 with six
participants (40%) from Depcat 3 and two participants (13.3%) from Depcat 4. Two
participants (13.3%) came from Depcat 5 and two participants (13.3%) came from
Depcat 6. No participants lived in the most or least affluent areas (Depcat 1 and 7
respectively).
















Living situation: With regard to the living situation of participants, twelve
participants (80%) lived with their parents, two participants (13.3%) lived with their
partner and one participant (6.7%) lived alone.
Working status: In relation to the working status of participants, nine participants
(60%) were attending school, three participants (20%) were in higher education, one
participant (6.7%) was in part-time work and two participants were not working due
to ill health (13.3%).
Treatment regimen: All participants reported that they were required to undertake
the four specified CF treatment regimen tasks including medication, physiotherapy,
diet and exercise on a daily basis. With regard to the self-report estimate of
adherence over a one-week period, all participants reported that the previous week
had been a 'typical' week with no major life events reported. It was therefore
considered that their estimate of adherence over the one-week period was
representative of their general adherence to the treatment regimen.
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3.1.4 Summary of Questionnaire Data
A summary of data obtained from the five questionnaire measures completed by
participants is shown in Table 4. The table includes the means, standard deviations
and range of scores on the measures.
Table 4: Details of responses to questionnaire measures
Variables N Mean SD Min. Max.
The Health Care Climate Questionnaire 15 81.73 11.56 62 99
The Self-efficacy Questionnaire 15 24.27 3.77 18 28
The Treatment Self-regulation
Questionnaire
- Autonomous Subscale 15 45.13 6.99 33 55
- Controlled Subscale 15 23.60 8.56 9 35
The Hospital Anxiety and Depression
Scale
- Anxiety Subscale 15 6.93 4.10 0 13
- Depression Subscale 15 3.47 3.11 0 9
The Self-report Adherence Measure
- Adherence to Medication 15 3.30 .528 2 4
- Adherence to Physiotherapy 15 2.10 1.18 .5 4
- Adherence to Diet 15 3.40 .687 2 4
- Adherence to Exercise 15 3.00 .964 1 4
Emotional Well-being: A frequency distribution of scores for all participants on the
Hospital Anxiety and Depression Scale is illustrated in Figure 4. On the anxiety
subscale, seven participants (46.7%) fell within the 'normal' range of scores (0-7),
five participants (33.3%) fell within the 'mild' range of scores (8-10) and three
participants (20%) fell within the 'moderate' range of scores (11-14), demonstrating
clinical 'caseness' for anxiety. No participants presented with 'severe' levels of
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anxiety (15-21). On the depression subscale, thirteen participants (86.7%) fell within
the 'normal' range of scores (0-7) and two participants (13.3%) fell within the 'mild'
range of scores (8-10). No participants presented with 'moderate' or 'severe' levels
of depression.
Figure 4: Scores on the anxiety and depression subscales for all participants (n=15)
Normal (0-7) Mild (8-10) Moderate (11-14) Severe (15-21)
Scores
Relationship between gender, social deprivation category, severity of illness and
adherence to cystic fibrosis treatment regimen tasks: An Independent t-test was
conducted to investigate whether participants' gender had any effect on their
adherence. In addition, Pearson's Correlations were undertaken to examine whether
there were any relationships between social deprivation category, severity of illness




Table 5: Independent t-test examining effect of gender on participants'





Adherence to Medication 3.36 3.25 .380
(p=.355)
13 (NS)
Adherence to Physiotherapy 1.93 2.25 -.511
(p=.309)
13 (NS)
Adherence to Diet 3.36 3.44 -.218
(p=.415)
13 (NS)
Adherence to Exercise 2.86 3.13 -.523
(p=.305)
13 (NS)
Results indicate that there is no significant difference between male and female
participants on their scores on the measure of adherence to the four cystic fibrosis
treatment regimen tasks.
Table 6: Correlation comparing social deprivation category with participants'
adherence to cystic fibrosis treatment regimen tasks
Social Deprivation Category
N Pearson's Correlation Sig.
(one-tailed)
Adherence to Medication 15 -.270
(p= 165)
(NS)
Adherence to Physiotherapy 15 -.018
(p=.475)
(NS)
Adherence to Diet 15 -.431
(p=.054)
(NS)





There was no significant relationship between social deprivation category and
adherence to cystic fibrosis treatment regimen tasks.
Table 7: Correlation comparing severity of illness with participants' adherence
to cystic fibrosis treatment regimen tasks
Severity of Illness
N Pearson's Correlation Sig.
(one-tailed)
Adherence to Medication 15 -.097
(p=.366)
(NS)
Adherence to Physiotherapy 15 .285
(p=.151)
(NS)
Adherence to Diet 15 -.257
(p=.177)
(NS)
Adherence to Exercise 15 .122
(p=332)
(NS)
There was no significant relationship between severity of illness and adherence to
cystic fibrosis treatment regimen tasks.
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3.2 HYPOTHESES FROM THE LITERATURE
3.2.1 Hypothesis 1(a)
Autonomy supportive relationships between health care providers and adolescents
and young adults with CF will be associated with greater autonomous motivation to
adhere. Research has suggested that patients display greater autonomous motivation
to adhere when they perceive their health care providers as being autonomy
supportive. A Pearson's Correlation was conducted to test for a relationship between
the scores on the measures of health care providers' relationship style and
participants' motivation to adhere as shown in Table 8.
Table 8: Correlation comparing health care providers' relationship style with
participants' motivation to adhere
Health Care Providers' Relationship Style
N Pearson's Correlation Sig.
(one-tailed)
Motivation to Adhere 15 .566
(p=.014)
p<0.05
Results indicate that there is a meaningful relationship between autonomy supportive
health care provider relationship styles and participants' autonomous motivation to
adhere (r = .566; n=15; p<0.05). An additional correlation was conducted between
scores on the measures of health care providers' relationship style and participants'
controlled motivation to adhere. As anticipated, no significant correlation was found
between autonomy supportive health care provider relationship styles and




Autonomy supportive relationships between health care providers and adolescents
and young adults with CF will be associated with greater self-efficacy. Researchers
have suggested that participants are more likely to display increased self-efficacy
when they perceive their health care provider as autonomy supportive. Scores on the
measure of perceived health care providers' relationship style were compared with
scores on the measure of self-efficacy. A Pearson's Correlation was conducted to test
for a relationship between these variables as illustrated in Tables 9.
Table 9: Correlation comparing health care providers' relationship style with
participants' self-efficacy
Health Care Providers' Relationship Style





Results indicate a meaningful correlation between autonomy supportive health care
provider relationship styles and participants' self-efficacy (r = .689; n=15; p<0.01).
3.2.3 Hypothesis 1(c)
Autonomous motivation to adhere will be associated with greater self-efficacy.
Research suggests that when participants display autonomous motivation to adhere,
they will also display greater levels of self-efficacy. Scores of participants'
motivation to adhere were compared with scores on the measure of self-efficacy.
This analysis was conducted using a Pearson's Correlation as shown in Table 10.
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Results indicate that there is a meaningful relationship between participants'
autonomous motivation to adhere and their self-efficacy (r = .478; n=15; p<0.05).
An additional correlation was conducted between scores on the measure of self-
efficacy and participants' controlled motivation to adhere. As anticipated, no
significant correlation was found between self-efficacy and participants' controlled
motivation (r = .294; n=15; p = .144).
3.2.4 Hypothesis 1(d)
Adolescents and young adults who report greater self-efficacy will display increased
adherence to CF treatment regimens. Research has indicated that greater self-efficacy
results in improved adherence. Scores on the measure of self-efficacy were compared
with scores of adherence to each of the four individual CF treatment regimen tasks.
A Pearson's Correlation was carried out to compare scores as illustrated in Table 11.
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Table 11: Correlation comparing participants' self-efficacy with adherence to














Adherence to Diet 15 .466
(p=.040)
p<0.05
Adherence to Exercise 15 .098
(p=364)
(NS)
Results indicate that there is a meaningful relationship between participants' self-
efficacy and adherence to diet in adolescents and adults with CF (r = .466; n=15;
p<0.05). No significant correlations were found between participants' self-efficacy
and their adherence to medication, physiotherapy or exercise.
The results provide some evidence that the self-determination model of human
motivation could be applicable within the CF population, since meaningful
relationships were found between autonomy supportive health care providers and
participants' autonomous motivation to adhere and between participants'
autonomous motivation to adhere and participants' self-efficacy. Furthermore, there
was a meaningful correlation between participants' self-efficacy and their adherence
to diet. As there was a meaningful correlation between autonomy support from health
care providers and participants' self-efficacy, a partial correlation was conducted
controlling for participants' autonomous motivation to adhere to establish whether
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autonomous motivation was a mediating variable between autonomy support and
self-efficacy. The results of the partial correlation are presented in Table 12.
Table 12: Partial correlation comparing health care providers' relationship
style with participants' self-efficacy whilst controlling for participants'
autonomous motivation to adhere
Health Care Providers' Relationship Style





The correlation between health care providers' relationship style and participants'
self-efficacy, when controlling for participants' autonomous motivation, was less
significant (r = .577; df = 12; p<0.05). The results therefore suggest that participants'
autonomous motivation to adhere is a mediator in the link between autonomy
supportive health care providers and participants' increased self-efficacy.
3.2.5 Hypothesis 2
Lower levels of psychological distress (anxiety and depression) will be reported by
adolescents and young adults with CF who perceive their health care providers as
autonomy supportive. Research indicates that individuals who perceive their health
care provider as being autonomy supportive will display better psychological
adjustment. Scores on the measure of perceived health care providers' relationship
style were compared with scores on the measure of psychological well-being. This
analysis was carried out using a Pearson's Correlation as shown in Table 13.
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Table 13: Correlation comparing health care providers' relationship style with
participants' psychological well-being
Health Care Provider's Relationship Style








No significant correlations were found between autonomy supportive health care
providers and participants' levels of anxiety and depression, although the results
suggest a trend in the hypothesised direction with lower levels of anxiety and
depression being experienced if health care providers are perceived as autonomy
supportive.
3.2.6 Hypothesis 3
Adolescents and young adults with CF who report greater self-efficacy will display
lower levels of psychological distress (anxiety and depression). Research indicates
that individuals with high self-efficacy display better psychological adjustment.
Scores on the measure of self-efficacy were compared with scores on the measure of
psychological well-being. This analysis was carried out using a Pearson's Correlation
as shown in Table 14.
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Table 14: Correlation comparing participants' self-efficacy with their
psychological well-being
Self-efficacy








No significant correlations were found between participants' self-efficacy and their
levels of anxiety and depression, although the results suggest a trend in the
hypothesised direction with lower levels of anxiety, in particular, being experienced
if participants' self-efficacy is high.
3.3 EXPERIMENTAL HYPOTHESES
3.3.1 Hypothesis 4
Higher levels of psychological distress (anxiety and depression) in adolescents and
young adults with CF will be associated with poorer adherence to CF treatment
regimens. Researchers indicate that emotional distress can have a negative impact on
adherence to treatment regimens. Scores on the measure of psychological well-being
were compared with scores of adherence to each of the four individual CF treatment
regimen tasks. Pearson's Correlations were conducted as shown in Table 15 and 16.
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Table 15: Correlation comparing levels of anxiety with adherence to cystic
















Adherence to diet 15 -.168
(p=.275)
(NS)
Adherence to exercise 15 .208
(p=228)
(NS)
Table 16: Correlation comparing levels of depression with adherence to cystic
















Adherence to diet 15 -.361
(p=.093)
(NS)
Adherence to exercise 15 -.095
(p=.368)
(NS)
The results suggest no significant correlations between participant's levels of anxiety
and depression and their adherence to the individual CF treatment regimen tasks.
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However, the results suggest a trend in the anticipated direction particularly for
adherence to diet, with poorer adherence to this individual regimen task occurring if
higher levels of depression are experienced (r = -.361;n=15; p = .093).
3.3.2 Hypothesis 5
Increased age will be associated with better adherence to CF treatment regimens.
Research in chronic health conditions has suggested that adolescence is linked with
poorer adherence to treatment regimens. It was therefore hypothesised that the
younger the age of the sample, the poorer the adherence. Age was compared with
scores of adherence on each of the CF treatment regimen tasks. This analysis was
conducted using a Pearson's Correlation as illustrated in Table 17.

















Adherence to diet 15 .367
(p=.089)
(NS)





Results suggest that there is a meaningful negative correlation between adherence for
physiotherapy and age (r = -.491; n=15; p<0.05). No significant correlations were
found between age and adherence to medication, diet or exercise.
3.3.3 Hypothesis 6
Increased severity of CF will be associated with increased psychological distress
(anxiety and depression). It was hypothesised that adolescents and young adults with
CF will display increased levels of psychological distress as their condition
deteriorates. Scores on an objective measure of severity of illness (FEV1 %
predicted) were compared with scores from the measure of psychological well-being.
A Pearson's Correlation was carried out to compare the scores as shown in Table 18.













No significant correlation was found between severity of condition and levels of
anxiety or depression in adolescents and young adults with CF. However, results
indicate a trend in the anticipated direction for anxiety with increased anxiety being





All sixty-seven individuals approached to participate in the main study were invited
to attend a semi-structured interview with the researcher following the completion of
the questionnaire measures. Of the fifteen individuals who returned the questionnaire
measures, nine individuals agreed to attend an interview, although one individual
failed to attend the arranged appointment. Consequently eight participants were
interviewed for the study. All the interviews were tape-recorded with participants'
consent and were fully transcribed afterwards. A summary of the participants who
attended the interview is given below in Table 19.
Table 19: Descriptive information on participants who attended the semi-














1 Male 12 36 65 All the above
2 Female 14 1 85 All the above
3 Male 12 2 80 All the above
4 Female 14 3 99 All the above
5 Female 19 5 83 All the above
6 Female 19 2 83 All the above
7 Male 26 24 53 All the above




It is important to outline researcher bias before the analysis of the interview data. In
the current study, researcher bias was directed towards factors influencing adherence
to treatment regimens and reasons for non-adherence. In addition, the bias that health
care providers perceived by participants as autonomy supportive would influence
participants' motivation to adhere and self-efficacy was also evident.
3.4.3 Data Analysis
A thematic analysis of the interview data was undertaken for each respondent.
Repeated readings of interview transcripts were carried out to identify themes and
similar experiences and events were grouped together in categories. Current literature
on adherence in CF, psychological well-being in chronic illnesses and self-
determination theory was also consulted to facilitate the development of themes for
the analysis. The main themes explored were taken from research by Rapoff (1999),
Angst (2001) and Williams et al (1998a). Due to time constraints a more thorough
analysis of the data using a grounded theory approach was not conducted but the
most relevant findings are presented.
3.4.4 Themes Identified
The most salient themes identified that corresponded to the aims of the study were
split into four broad categories as outlined in Figure 5.
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Figure 5: The main categories identified from the interview transcripts that
correspond to the aims of the study
Examples from each of the above categories are presented overleaf. For each theme,
respondents who mentioned the particular theme are identified in brackets.
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3.4.4.1 Impact of Cystic Fibrosis on Participants' Lifestyles
Effect ofFrequent Hospital Admissions
Five respondents discussed the impact of frequent hospitalisations on their life. Three
of the individuals reported missing their family whilst in hospital and one respondent
in particular reported feeling isolated as they required to be segregated from the other
CF patients within the ward because they had Burkholderia cepacia. Two
respondents reported that they enjoyed being in hospital as it was an opportunity to
meet up with their peers with CF.
"I came out of hospital about three weeks ago...was getting IV's. I don't like going
into hospital, it's boring, there is nothing to do...I miss my mum and family but mum
visits every day and its great to get home and see everyone"
"I don't like being in hospital too often...I'm not allowed in the bay with the other
CF children as I have Burkholderia cepacia...I miss my family" (2,3,8)
"My friend is usually in hospital when I am...it's more fun...we share a room" (1,7)
Effect ofCF on Schooling
The majority of respondents reported having missed a substantial amount of school
due to their condition. However, it appeared that the schools had been
accommodating by permitting the individuals to come in later in the mornings, so
that they could complete their morning treatment regimens, and sending work home
during long periods of ill health in an attempt to prevent the respondents from falling
behind with their academic work. Two respondents commented on parental concerns
that they may be bullied about their CF within the school environment although they
indicated that they had encountered no such problems.
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"I was off sick about half the time I was at school...school sent me homework if I
was off for long periods. Even if I was in hospital there was a teacher there so I
didn't get out of working even if I was ill"
"I'm on a half-time curriculum because of my CF...if I'm off for a while I get sent
homework"
"I'm off a lot...it's not good because I miss the work" (1,2,3,5,7,8)
"School make allowances for me getting time off school for appointments or coming
in later in the mornings because ofmy treatments" (4,5,6)
"Mum and dad were worried that I would be bullied about my CF but I never was"
"I never felt segregated or embarrassed or anything like that at school...mum and
dad worried I may be bullied or something because of the CF but I wasn't" (2,6)
Effect ofCF on Employment
The three young adults who attended the interview commented on the effect of CF
on their choice of employment. One adolescent discussed their parents' lowered
expectations of their future employment.
"Originally I wanted to be a mid-wife or nurse but I wasn't allowed to do that
because of the risk of cross infection. I'm doing primary school teaching now at
college.. .it's a sense of achievement"
"I went to college to do a catering course and got a job in an industrial kitchen but it
was too hot and when I'd leave at night and go outside the air was cold and I got a lot
of chest infections. I had to give it up as I couldn't work in the kitchens.. .so I wasted
the two years at college" (5,6,7)
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"Mum is not as ambitious for me career wise as she is for my sisters. All she wants is
for me to remain healthy" (4)
Relationships and Fertility Issues
All of the young adults reported that they were currently in a relationship with a
supportive partner. One of the young adults discussed concerns regarding their
ability to cope with pregnancy in view of their condition and another spoke of the
impact of being infertile on a previous relationship.
"I have been living with my boyfriend for six years, he's very supportive about my
CF" (5,6,7)
"I do have some worries about starting a family. How will I cope with the
pregnancy? I also worry about my child's health and the effect of me having CF on
my children" (6)
"I was engaged once but my fiance got pregnant. There were questions about my
fertility because of the CF...I found out I was not the father...the relationship ended"
(7)
Concerns about Future Health
Five respondents reported that they did not think about their future health. Three of
these individuals reported that they had no concerns since their CF was relatively
well controlled at present, compared to some of their peers with CF. The other two
individuals commented on the possible impact that their peer-related activities may
have on their health.
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"I don't think about it, I just get on with my life"
"I don't worry about what will happen as I get older, I don't think about it...I live
each day as it comes" (2,4,5,6,7)
"I don't have any worries about my health in the future.. .1 have kept healthy to date"
"I'm more healthy that lots of other people with CF I know" (2,5,6)
"My liver is not in good shape. I'll have to watch with alcohol. Mum keeps saying I
can't binge at parties or I'll damage my liver"
"My asthma has been bothering me at the moment...I need to use the inhaler a lot
which gets annoying. It's probably because I smoke a lot. I keep getting told to stop
and give up...I managed for a few months but it's really difficult because if I'm at
the pub with my pals and they are smoking it's really hard not to join them" (4, 7)
One of the respondents who reported having no current concerns about their future
health stated that this had not always been the case.
"I had an older sister but she died of CF 10 years ago this year...she was very ill. I
found it hard at times after her death...I was worried about having CF and worried
about my health. I concentrated on my physio and medication for a few years
afterwards so that my condition did not worsen" (6)
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3.4.4.2 Emotional Well-being in Participants
Emotional Reactions to CF
A variety of emotions relating to the condition were reported by all respondents. Two
respondents commented that maintaining a positive mood played an important part in
helping them manage their condition.
"My nature helps me to cope with CF...its my nature to stay positive"
"I try to stay positive and not let it (CF) affect my life" (2,4)
Five respondents reported experiencing problems with anxiety or low mood as a
result of their condition. Concerns about the implications of poor weight gain and the
need for regular intravenous antibiotics were given as particular examples.
"I'm not gaining weight or height...it's worrying. The doctors suggested that I
needed a peg tube so that I can get overnight feeds but I don't want one inserted as
I've had enough operations... I don't want a tube in my stomach" (1)
"When I get IV's I do get fed up at times and feel down. You can't stay with friends
or have a shower or dress easily. IV's are more invasive.. .you depend on your family
and friends at these times to pick you back up when you feel low" (2,4,6,7)
Five respondents described feelings of embarrassment in social situations because of
their CF-related symptoms and treatments, particularly the need to take pancreatic
enzymes with every meal and snack.
"I used to be quite embarrassed about taking Creon at school, people wonder what
you are doing...I've got used to it though"
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"I don't like taking Creon in front of others, if I go out at night I usually take the
Creon before I go out. I don't like having to explain...people see you taking tablets
at lunchtime and ask you questions about what they're for. Sometimes I take them in
the toilet before lunch at school so people don't see me taking them" (1,4,7,8)
"People think I have problems with asthma because of my cough...I don't but my
cough is there all the time. It was a bit awkward and embarrassing at school" (5)
Six individuals described feelings of frustration regarding the constant need for
treatments for their condition. The time consuming nature of physiotherapy and its
impact on social activities was a particular issue for respondents.
"I don't really feel down but I get fed up at times about having to do everything...the
constant treatments.. .it takes so long" (4)
"Having to get physio and take tablets every day can be annoying. It uses up a lot of
your time when you could be out playing"
"I still go out with my friends but I have to make time to do my treatments. You need
a lot of time to do everything. If I want to go out with my friends I have to be back
home by 7pm to fit everything in before bedtime...that's too early"
"It can be annoying if I want to stay out for longer but I know it (treatment) takes
about two hours to do in total so I need to make the time before bed" (1,2,3,8)
"The frequent chest infections and breathing difficulties are frustrating especially if I
want to go out but I'm coughing all the time, it's annoying. I've been in hospital a lot
recently so I can't think about work at the moment. It gets really frustrating sitting
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around here all day. It used to annoy me if I was doing PE at school and got
breathless or tired really easily" (7)
One respondent also commented on the frustration at the unpredictability of the
condition
"Sometimes 1 do everything I'm meant to and still get ill, that's frustrating" (2)
Importance ofSupport ofSignificant Others
All respondents commented on the importance of emotional support from their
parents in helping them to manage their condition. Five individuals also mentioned
the importance of having supportive friends.
"I have a very close family, they are very supportive of me...they want me to get on
with my life as best as I can"
"If plans change at last minute because I'm ill, that's just the way it is...everyone
makes allowances...we cope with the CF together"
"My family, fiance and his family are all very supportive about my CF...you depend
on your family at times" (1,2,3,4,5,6,7,8)
"A lot of my friends know about it (CF) and are very good about it...especially my
friends from primary school"
"My close friends are caring and understanding, it makes it easier to cope" (2,4,5,6,7)
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Six respondents commented on the importance of practical support from parents to
help them to undertake the required treatments, particularly physiotherapy. One
individual spoke of the assistance she received from her friends.
"Mum and dad help me a lot.. .they take turns to do my physio with me" (1,2,4,5,6,7)
"I have three really close friends...they come to stay and help me with my physio
and setting up my overnight feeds" (2)
Importance ofAcceptance of the Condition andMaintaining a Sense ofNormality
Five respondents commented on the importance of acceptance of their condition in
maintaining their emotional well-being.
"I feel normal, obviously its not normal but to me it is...I have not known any
different.. .I've had it (CF) all my life.. .my treatment is part of normal life to me"
"I'm active and healthy and CF does not really affect my lifestyle at the moment. I
just get on with it...I have no choice. I don't let CF get me down...I'm not going to
let it ruin my life. I do the best I can"
"Its just a habit now. It did affect me a lot after my sister died but as I have got older
I have just got on with it. I've had it for so long" (2,3,4,5,6)
Six respondents commented on the importance of maintaining a sense of normality to
enable them to cope with living with a chronic condition.
"I have to get home IV antibiotics every few months but we try to make everything
as normal as possible so I can get on with my life. I was in a school play the last time
I had IV's and just fitted them around the play"
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"We take my CF as part of everyday living.. .I've never really missed out on things"
"I still go out with my friends and go away for weekends but I have to make time to
do my treatments. When I go for a sleepover I'm allowed the night off from my
overnight feed...I usually have my physio and nebulizer before I go and then have it
a little later in the morning when I get back home the next day" (1,2,4,5,6,8)
3.4.4.3 Adherence Issues
Reasonsfor Adherence
Four respondents reported that they adhered to their treatments since they considered
them to be important in maintaining their health. One individual spoke of the
negative effects of non-adherence to the pancreatic enzymes which encouraged them
to remember to take the enzymes in future. Two adolescents commented that parental
reminders were the main reasons for their adherence to treatments. In addition, five
respondents emphasised the importance of establishing a routine to ensure that the
complex treatment regimen required for the condition was undertaken.
"I have always taken the tablets and done my physio pretty much everyday...I know
I will get a lot worse if I don't... my cough gets more frequent and I get tired"
"I do all my treatments to make sure that I stay healthy" (2,4,5,6)
"Sometimes I forget to take my tablets but I suffer the next day. If I'm at a party and
have some 'nibbles' I won't think to take my Creon as I don't think I'm eating much
but then I'll need the next few days off work as I have bad stomach ache" (6)
"My mum and dad remind me all the time to do my treatment" (1,3)
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"We have a routine to get everything done, that helps. It'd be difficult to fit
everything in otherwise...! don't know if I'd do it otherwise"
"Treatment is part ofmy daily routine now. I don't think about it, I just do it"
"You get used to taking the tablets whenever you get up or with meals, you do it
Reasonsfor Non-adherence
The treatment in which motivation appeared to be lowest for the majority of
respondents was physiotherapy due to the time-consuming nature of the task which
impacted on their lifestyle and the lack of any immediate benefit.
"If I am too tired at night I sometimes can't be bothered with physio"
"Doing physio everyday can be annoying. It uses up a lot of your time" (1,2,3,7,8)
"I'm meant to do physio and take my nebulizers daily but I don't really do them...it
hasn't made any difference to my condition...I do physio though if I am feeling
Five of the respondents reported that their parents encouraged and assisted them to
undertake their physiotherapy even though four of the respondents had previously
reported low motivation regarding this regimen task.
"My parents take turns to do my physio with me, I don't know if I would do it





Two respondents reported that low mood had an impact on their adherence to
treatments.
"When you feel down you don't feel like doing anything including treatments" (2,7)
Forgetfulness was also reported by three respondents as a reason for non-adherence
to treatments, particularly medication.
"I'm meant to take my tablets four times a day and don't always take the ones during
the day because if I am out 1 can't be bothered going back home for them or I forget
them" (2,6,7)
No respondents referred specifically to a period of rebellion during their teens which
was associated with a lack of adherence to treatment.
MostDifficult Treatments to Adhere to
The majority of respondents reported that the most difficult treatments to adhere to
were physiotherapy and intravenous antibiotics.
"I find coughing stuff up and spitting it out during physio difficult, it's not nice"
(1,2,3,6)
"When I get IV's I do get fed up at times and feel down. You can't stay with friends
or have a shower or dress easily. IV's are more invasive...you depend on your family
and friends at these times to pick you back up when you feel low"
"Home IV's, that can be a hard time as I can't go out.. .it's harder to cope then.. .1 get
so tired but it keeps you healthy" (2,4,6,7)
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3.4.4.4 Relationships with Health Care Providers
Satisfaction with the CF Team
There was generally a high level of satisfaction with the CF teams. The majority of
respondents reported finding the members of the team supportive on both an
emotional and practical level.
"I feel at ease with them (CF team)...had CF all my life so I've known them for
ages. They are very supportive"
"I still go to the paediatric clinic, the doctor makes me feel listened to. He has got
children who are the same age as me and knows how to speak to children and explain
things so that I understand them, the language he uses is good"
"I've had a close relationship with my nurse ever since my sister died. She has really
helped me and I know I can contact her whenever I want. She is more like a
friend.. .if you can't speak to your family about something then the nurses are always
there at the end of the phone. Some things like pregnancy are difficult to discuss with
your family but it's easy to speak to the nurses" (1,2,4,5,6,8)
"Most of the time the nurses can sort out any queries I have even if it is a small one"
"If I ask questions then the nurse will try and find out as much information as
possible and relay the information back to me...they support you really well"
(2,4,5,6,7)
Negative Experiences with Health Care Providers
Two respondents expressed a desire for their CF nurse to spend more time getting to
know them as a person, believing that at times the nurse was more concerned with
getting their job done than trying to form a relationship with them.
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"Its good when someone treats me as a person as opposed to someone with CF and
tries to get to know me a bit too. The nurse sees me as my CF first and then as
me...she is good at her job but it's a bit less personal. It would be nice if she was a
bit more friendly" (2,3)
Three respondents described instances of conflict with their consultants regarding
their treatment. One respondent reported that they did not always understand the
language used within the adult CF clinic. Generally, however, respondents were
satisfied with the services received.
"I was ill...the doctor at the adult clinic thought I was not taking the medication to
combat the infection and sort of accused me of not taking it when I was...I felt
annoyed and quite upset that he didn't believe me" (2,8)
"I don't think that the tablets are helping me so I don't take them now...the doctor
keeps insisting that I take them...there's a bit of a battle going on about it at the
moment" (6)
"I had to go to the adult clinic for a while because I colonized Burkholderia
cepacia...sometimes the doctor said things that I didn't understand. The doctor at the
paediatric clinic explains things so that I understand them though...the language he
uses is good " (2)
Importance ofAutonomy in Treatment
Five respondents commented on the importance of being kept informed about their
condition and being included in discussions regarding changes to their treatment
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regimens. A sense of autonomy within clinic settings was considered to be extremely
important to the young adults in particular.
"They tell me why everything is being done and I'm kept well informed...I do get
choices about some things like whether to get the peg tube fitted"
"I usually feel that I can get my point across with the team, definitely can with the
nurses"
"I started going to see the doctor myself at the adult clinic... I felt more like an adult.
1 get a say in my treatments...they ask for your opinion and get your feedback on
whether or not you think the treatment is working"
"I am given a say in my treatment, the doctors and nurses always ask if you are
happy for changes in doses etc...they are very good at telling you all you need to
know about the treatments...I feel included"
"It's better in the adult clinic because when I was 15/16 years old 1 got told what was
best for me. Now they ask you what you think is best which is a good part of it.. .you
get more of a say... they ask for your opinion" (1,2,4,6,7)
Four respondents spoke of the difficulties that their parents had encountered
regarding the transfer of responsibility for treatment to the individual following the
transition to adult CF services.
"Mum finds it difficult as she liked to know what was going on"
"My mum found it difficult not being so involved...she still asks me what the doctor
said after each clinic and I fill her in"
"Mum used to do all my treatments with me...she doesn't see me do it now but she
checks the pills in the cupboard are going down I think" (4,5,6,7)
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Confidence in Undertaking Treatments
Five of the respondents reported feeling confident in their ability to undertake their
treatment regimens. Two individuals mentioned that the CF nurses had spoken with
them at length about undertaking various regimen components which had helped to
increase their belief in their competence to carry out the tasks.
"I feel confident about carrying out all the parts ofmy treatment" (2,4,5,6,8)
"The nurses made sure that my parents and I knew how to administer the overnight






4.1 GENERAL SUMMARY OF RESEARCH
The principal aim of the current study was to apply the self-determination theory of
human motivation to explore the relationship between health care professionals'
interpersonal styles and adolescents and young adults' adherence to CF treatment
regimens. Although the self-determination theory has been applied within other
chronic health conditions, there has been no research to date exploring these issues
within the CF population. Since less than optimal adherence has been reported in CF
patients with significant health implications, information on factors that encourage
adherence to regimen tasks is of great importance. The current study also aimed to
examine the personal meaning of having CF in adolescents and young adults and
includes information on eight individuals who attended for an interview to discuss
their experiences in detail. Information was obtained from the interviews regarding
the impact of CF on the participants' lifestyles, their emotional reactions to the
condition, reasons for adherence and non-adherence to treatment regimens and
preferred health care provider relationship styles.
4.2 SUMMARY OF DEMOGRAPHIC DATA
The current study replicates previous literature by Helton, Harmon and Robinson
(1991) suggesting that most individuals with CF are diagnosed within the first 15
months following birth, with 73.3% of participants having been diagnosed with CF
within the six months following birth. In addition, Shepherd, Hovell and Harwood
(1990) reported that adults with CF who were not married or co-habiting were likely
to live alone or with their parents compared to their healthy peers who were likely to
live with their friends or flatmates. Although the majority of the participants within
the current study were adolescents, all of whom were living with their parents, the
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study found that of the young adults with CF, three were still living in the parental
home with two individuals co-habiting and one participant living alone. Conway
(1998) claims that many young adults with CF find it difficult to become fully
independent from their parents, on whom they have been dependent for many years
for assistance with aspects of their treatment. During the semi-structured interviews
two of the young adults who still lived at home reported no immediate plans to move
away from the parental home in view of the emotional and practical support they
received from their parents and this is in line with Conway's findings. Furthermore,
Ricker, Delamater and Hsu (1998) investigated correlates of regimen adherence in
children with CF and their families and stated that there was no relationship between
adherence and gender, socio-economic status and severity of illness. Within the
current study, an Independent t-test and Pearson's Correlations were undertaken to
ascertain whether there was a relationship between these variables. No significant
results were obtained thereby agreeing with the findings reported by Ricker et al.
4.3 DISCUSSION OF THE HYPOTHESES FROM THE LITERATURE
4.3.1 Hypotheses 1(a), (b) and (c): There will be an association between health
care providers perceived as autonomy supportive and participants' autonomous
motivation to adhere and increased self-efficacy.
Previous longitudinal studies have examined the influence of the self-determination
model on adherence behaviours in a variety of chronic health conditions. Self-
determination theory posits that when health care providers are perceived as
autonomy supportive, patients display increased autonomous motivation to behave in
a particular manner. Furthermore, patients feel more competent to carry out a variety
of health related behaviours, resulting in increased adherence to treatment regimens
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and improved health outcomes (Deci et al, 1994). In view of these research findings
it was predicted that adolescents and young adults' with CF who perceived their
health care provider as being autonomy supportive would demonstrate greater
autonomous motivation to adhere to their treatment regimens. A bivariate correlation
was undertaken and the results supported the hypothesis since there was a
meaningful positive correlation at p<0.05 between patients' perceptions of autonomy
support from health care providers and their autonomous motivation. In particular,
participants' perceptions of autonomy supportive health care providers were
meaningfully correlated with their beliefs that looking after their CF was the most
important reason for them remaining healthy (r = .566; n=15; p<0.05) and that
effectively looking after their CF was one of the many important aspects of their life
(r = .678;n=15; p<0.01). In view of research by Williams et al (1998b) that self-
efficacy is enhanced within the context of an autonomy supportive relationship, it
was also hypothesised that adolescents and young adults with CF would display
greater self-efficacy if they perceived their health care providers as autonomy
supportive. A bivariate correlation was undertaken on these variables and the results
indicated that there was a meaningful positive correlation between health care
providers perceived as autonomy supportive and greater participants' self-efficacy
(r = .689; n=15; p<0.01). In particular, participants' perceptions of autonomy
supportive health care providers were correlated with their feelings that they were
able to meet the challenge of looking after their CF (r = ,752;n=15; p<0.01) and also




Furthermore, Williams et al (1998a) reported that autonomous motivation was
related to a significant increase in diabetic patients" belief in their competence to
regulate their glucose levels. A bivariate correlation was therefore conducted to
examine whether autonomous motivation to adhere to CF treatment regimens was
associated with greater self-efficacy in participants. The results suggested that there
was a meaningful relationship between participants' autonomous motivation to
adhere and their self-efficacy (r = .478; n=15; p<0.05).
The aforementioned results indicate the importance of an autonomy supportive
relationship between health care providers and CF patients, since autonomy support
was positively associated with both greater autonomous motivation to adhere and
self-efficacy in the participants. Within CF clinics, health care providers are required
to educate their patients about the condition and its management and inform them of
the importance of consistent adherence to regimens for future health outcomes. The
results of the current study would suggest that it is not sufficient solely to provide
patients with this information. Flealth care providers are required to adapt
information depending on the cognitive developmental level of the patient in order to
ensure understanding and also to consider the implications of the condition and its
treatment on the individual's lifestyle. In addition, self-determination theory
emphasises that patients should be provided with an opportunity to ask questions and
voice concerns regarding the proposed regimens since individuals will display
increased interest in particular behaviours being supported by health providers, such
as the importance of consistent adherence to regimens, if they perceive themselves to




Moreover, Williams et al (2000) state that providers perceived as controlling will
cause patients to feel coerced to behave in a particular manner and Williams et al
(1999) report that a controlling relationship may also increase anxiety levels within
the individual, with any behaviour change likely to be short lived and poorly
integrated into the individual's long-term values. An additional bivariate correlation
was therefore conducted to ascertain whether perceptions of autonomy supportive
health care providers were related to controlled motivation to adhere. As would be
predicted from the self-determination model, no significant correlation was found
between autonomy supportive health care provider relationship styles and
participants controlled motivation (r = .206; n=15; p = .231). Autonomy support was
not related to participants' feeling pressurised to behave in a certain manner and the
influence of autonomy support on patients' motivation to adhere is therefore an
important aspect for health care providers within CF teams to consider. An
additional correlation was conducted between scores on the measure of self-efficacy
and participants' controlled motivation to adhere. As would be anticipated, no
significant correlation was found between self-efficacy and participants' controlled
motivation (r = .294; n=15; p = .144). One of the most interesting findings of the
current study was the significant relationship between providers perceived as
autonomy supportive and participants' self-efficacy. It would therefore appear to be
important for health care providers to develop an understanding of patient's beliefs
in their own competence to carry out treatment regimens in addition to providing
them with choices and a say in decisions regarding the management of their
condition in order to encourage more consistent adherence to regimens.
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4.3.2 Hypothesis 1(d): Adolescents and young adults who report greater self-
efficacy will display increased adherence to CF treatment regimens.
In view of findings by O'Leary (1992), Bartholomew et al (1993) and Williams et al
(1998a) that self-efficacy has an influential effect on adherence behaviours, it was
anticipated that there would be a correlation between increased self-efficacy and
greater adherence to treatment regimens. The results of the current study indicated
that there was a meaningful relationship between participants' self-efficacy and their
adherence to diet (r = .466; n=15; p<0.05), although no significant correlations were
found between participants' self-efficacy and their adherence to medication,
physiotherapy or exercise.
The majority of respondents who attended the semi-structured interviews commented
that the first regimen task that they were given responsibility for undertaking was the
consumption of pancreatic enzymes within the school environment and they reported
feeling competent to manage this task. Furthermore, they reported that non-
adherence to pancreatic enzymes was associated with immediate negative symptoms
of abdominal pain that consequently encouraged them to take their enzyme
replacements. It may be that parents were more influential in the individual's
adherence to physiotherapy by way of frequent reminders and assistance to undertake
the regimen task. In addition, parents may look after medication and tablets required
by children and adolescents and administer them when required. Furthermore,
exercise is generally included as part of the school curriculum. Adherence to these
three treatment components, particularly during adolescence, are therefore unlikely
to be influenced by whether or not an individual feels competent to carry them out
thereby accounting for the non-significant results obtained. A larger sample size is
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required to confirm this result, since a post-hoc power calculation indicated that there
was only a 20%, 16% and 5% (respectively) chance of detecting a significant
relationship between the variables with the current sample.
The self-determination model developed by Williams et al (1998a) is illustrated in
Figure 6 below and shows that patients' perceptions of autonomy support from
health care providers results in increased autonomous motivation to adhere in
diabetic patients. This in turn results in an increase in perceived competence and
consequently better adherence.
Figure 6: The self-determination model (Williams, Freedman and Deci, 1998a)
The results of the current, investigative study provide some evidence that the self-
determination theory could be applicable within the CF population since meaningful
correlations were obtained between the factors inherent within the theory. Although
correlations do not necessarily imply causality, this study demonstrates that there are
particular relationships between the perception of autonomy supportive health care
providers and participants' autonomous motivation to adhere and their self-efficacy.
Furthermore, the results suggest a relationship between participants' self-efficacy
and their adherence to the dietary regimen task.
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Whilst controlling for autonomous motivation to adhere, a partial correlation was
conducted between autonomy support and participants' self-efficacy to establish
whether autonomous motivation was a mediating variable between autonomy
support and self-efficacy. The partial correlation suggested that autonomous
motivation was a mediator in the link between autonomy support and self-efficacy,
as suggested by the self-determination model, since the correlation between these
two variables was less significant when controlling for participants' autonomous
motivation (r = .577; df = 12; p<0.05). The finding suggests that autonomy support
had an impact on participants' self-efficacy regardless of whether the participant was
motivated to adhere, although autonomous motivation is a mediating variable. A
diagram of the results of the present study is displayed in Figure 7.
Figure 7: Diagram depicting the results of the current study
The model derived from the current study suggests that while autonomous
motivation is a mediating factor between autonomous support and self-efficacy,
autonomous support does appear to be directly associated with self-efficacy
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regardless of whether an individual is autonomously motivated to adhere. The cross
sectional nature of the study does not allow for causal interpretation of the results
and further studies of a longitudinal nature are required to investigate the causal
direction of the association between autonomy support, autonomous motivation and
self-efficacy. In addition, multiple regression analysis may have proved useful to
establish the relative importance of autonomy supportive relationship styles,
autonomous motivation and self-efficacy in predicting adherence to treatment
regimens. However, due to limited numbers of participants in this study a multiple
regression analysis was not conducted, although with a larger sample such detailed
analysis of the data may have yielded interesting results.
4.3.3 Hypothesis 2: Lower levels of psychological distress (anxiety and
depression) will be reported by adolescents and young adults with CF who
perceive their health care providers as autonomy supportive.
It was predicated that those participants who perceived their health care providers as
being autonomy supportive would demonstrate lower levels of psychological
distress. Williams et al (1999) undertook a longitudinal study of medical students
taking an interview course and suggested that when instructors were perceived as
autonomy supportive, the students displayed greater conceptual learning and better
psychological adjustment in terms of lower anxiety, higher self-esteem and more
positive affect. No significant correlations were found between perceptions of
autonomy supportive health care providers and levels of anxiety and depression in
the current study, although the results suggested a trend in the anticipated direction
with lower levels of anxiety and depression being experienced if health care
providers were perceived as autonomy supportive. Williams and colleagues claimed
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that autonomy support of instructors promoted the active engagement and a sense of
volition with respect to learning in the students who participated in their study. A
larger sample size may have shown more meaningful correlations between the
presence of autonomy supportive health care providers and the psychological well-
being of participants, with participants who do not feel coerced or pressurised to
behave in a particular manner reporting reduced levels of anxiety as suggested by
Williams et al. A post-hoc power calculation indicated that for the current study,
with a sample size of 15, there was only a 20% chance of detecting any significant
result between perceptions of autonomy support and anxiety and a 17% chance of
detecting any significant result between perceptions of autonomy support and
depression.
4.3.4 Hypothesis 3: Adolescents and young adults with CF who report greater
self-efficacy will display lower levels of psychological distress (anxiety and
depression).
O'Leary (1992) reported that participants high in self-efficacy were not only more
likely to adhere to medical regimens but were more likely to experience less stress
and negative emotional states. It was therefore anticipated that participants
presenting with high self-efficacy would report lower levels of psychological
distress. No significant correlations were found between participants' self-efficacy
and their levels of anxiety and depression, although the results suggested a trend in
the hypothesised direction with lower levels of anxiety, in particular, being
experienced if participants' self-efficacy is high. A larger sample size is required to
detect whether there is any significant association between self-efficacy and
psychological adjustment since a post-hoc power calculation indicated that there was
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only a 36% chance of detecting any significant result between self-efficacy and
anxiety and a 13% chance of detecting any significant result between self-efficacy
and depression.
4.4 DISCUSSION OF THE EXPERIMENTAL HYPOTHESES
4.4.1 Hypothesis 4: Higher levels of psychological distress (anxiety and
depression) in adolescents and young adults with CF will be associated with
poorer adherence to CF treatment regimens.
It was anticipated that psychological distress would impact negatively on adherence
to treatment regimens. However, no significant correlations were found between
participants' levels of anxiety and depression and their adherence to the individual
CF treatment regimen tasks. Nevertheless, the results suggested that higher levels of
anxiety and depression had a possible negative impact on adherence to diet in
particular (r = -.168; n=15; p = .275 for anxiety and r = -.361; n=15; p = .093 for
depression). Although the results indicate a weak relationship, this finding is in line
with previous literature which has reported on the negative effect of psychological
distress on adherence (Koocher et al,1990). Furthermore, this finding would be
expected due to the acknowledged impact of anxiety and depression on appetite.
Gilbert (2000) reports that as a result of the physical changes that occur within the
body during episodes of depression and anxiety, not only are energy levels and sleep
affected but a loss of appetite is also common.
One reason for finding no significant association between psychological distress and
reduced adherence to medical treatment, physiotherapy and exercise may be due to
the fact that the majority of participants in the sample fell within the 'normal' range
107
DISCUSSION
on the Hospital Anxiety and Depression Scale, with only three participants
demonstrating clinical 'caseness' for anxiety and no participants presenting with
clinical 'caseness' for depression. The sample group therefore did not present as
having particular difficulties with psychological distress thereby reducing the
likelihood that any association would be found. Furthermore, the qualitative data
obtained from the interviews suggests that, although the individual may be
experiencing problems relating to their emotional well-being, the emotional and
practical support from significant others, in the form of reminders and assistance to
adhere to their regimen tasks, may prevent the individual from neglecting their
regimens, thereby validating the non-significant results obtained in this study.
In addition, within the diabetes literature, Anderson, Nowacek and Richards (1988)
stated that the personal meaning of diabetes amongst adults was strongly related to
their self-care and the degree of psycho-social adaptation. The sample group in this
study appeared to display high levels of psycho-social adaptation to their illness and
this may explain the lack of any significant findings. The hypothesis was therefore
not supported. Consequently, a post-hoc power calculation was conducted which
indicated that there was approximately an 8% chance of finding any significant
relationship between reduced adherence to the dietary regimen task and levels of
anxiety and approximately a 27% chance of finding any actual relationship between
reduced adherence to the same regimen task and levels of depression. A larger
sample would therefore be required in future studies.
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4.4.2 Hypothesis 5: Increased age will be associated with better adherence to CF
treatment regimens.
It was predicted that increased age would be associated with better adherence, in
view of the substantial literature emphasising difficulties with adherence in
adolescents as a result of their search for independence and desire for acceptance by
peers which can outweigh the demands of a self-care regimen (Cameron and Gregor,
1987; Tyrrell, 2001). No significant positive correlation was found between
increased age and better adherence to the four regimen components examined in this
study and this hypothesis was therefore not supported. Nevertheless, the results did
suggest a meaningful negative correlation between adherence for physiotherapy and
increased age (r = -.491; n=15; p<0.05). This result could be attributed to the fact
that many CF patients require assistance with physiotherapy from their parents until
early adulthood (Conway, 1998). The qualitative data also indicated that many of the
respondents were regularly reminded and assisted to adhere to this specific regimen
task by their parents. Furthermore, the respondents who attended the interviews
commented on the importance of establishing a routine for their treatments,
particularly physiotherapy due to its time-consuming nature. Parental reminders to
adhere and the presence of a routine may have increased the likelihood of
physiotherapy being undertaken by the adolescents within the sample, particularly
since they were all living within the parental home whereas three of the young adults
in the sample were now living outwith the parental home and would therefore have
received less reminders and assistance from their parents to do their physiotherapy
on a daily basis. In addition, young adults who are trying to maintain a normal
lifestyle may decide not to carry out physiotherapy because of the time required to
undertake the task and the lack of immediate perceived benefits (D'Angelo and
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Lask, 2001). Due to the small sample size of the study and the lack of any significant
correlations, a post-hoc power calculation was conducted and indicated that there
was approximately a 12% chance of finding a significant relationship between
increased age and adherence to exercise and approximately a 26% chance of finding
an actual relationship between increased age and adherence to the dietary aspects of
the regimen. A larger sample would be required in future studies in order to ascertain
whether there is indeed any association between increased age and adherence to
medication, diet and exercise regimens.
4.4.3 Hypothesis 6: There will be an association between increased severity of
CF and increased psychological distress (anxiety and depression).
It was anticipated that as participants' health deteriorated, as indicated by a reduction
in their FEV1 % predicted, their levels of anxiety and depression would increase.
However, no significant correlation was found between severity of the condition and
levels of anxiety or depression in adolescents and young adults with CF.
Nevertheless, the results indicated a trend in the anticipated direction for anxiety in
particular, with increased anxiety being experienced with any deterioration in their
condition (r = -.336; n=15; p = .111).
There may be several reasons for the lack of an association between a deterioration
in health and levels of anxiety and depression. Respiratory failure is responsible for
97% of all CF deaths (Penketh et al, 1987) and lung transplantation is suggested if an
individual presents with a severe deterioration in lung function, as indicated by a
FEV1 of less than 30% of their predicted value, and a significant reduction in quality
of life (Dark and Corris, 1996). The suggestion that a patient requires lung
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transplantation can be highly stressful for patients and their families, since it implies
a serious risk of death. However, within the sample group an average FEV1 %
predicted value was calculated for the previous six months. The mean FEV1 %
predicted reading was 77.33 (SD=13.96) with a range of 52-99 thereby indicating
that none of the participants had an FEV1 % predicted reading near to the cut-off
implying the need for lung transplantation. The qualitative data also suggested that
all participants appeared to be functioning well within their daily life despite having
CF and this may partly explain the lack of any reported problems with anxiety and
depression. FEV1 % predicted can also be affected by respiratory infections and
consequently, even if an individual's FEV1% predicted was lower than usual, the
reduced reading might be attributable to a chest infection, which is often treated by
antibiotics or an increase in time spent on physiotherapy, as opposed to signifying a
deterioration in health and therefore not cause significant distress to the individual.
Furthermore, emotional reactions to any deterioration in health may be cushioned by
the level of emotional support available from significant others. The participants
interviewed indicated that they received regular input from the CF teams and felt
confident that any deterioration in health would be competently managed by the
team. In addition, Shepherd et al (1990) report that CF sufferers have a tendency to
perceive themselves as 'less severe' than their peers with CF. During the semi-
structured interviews, three respondents commented on this fact: "I'm more healthy
that lots of other people with CF I know". It may be that the individuals within this
study have adapted to their condition well, are well supported and are therefore more
able to cope with any deterioration in health. Although no measure of coping style
was utilised in this study, it may be interesting in future research to investigate
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whether particular coping styles have any impact on the level of psychological
distress experienced by CF patients during a deterioration in their condition. An
additional reason for the lack of any significant results may be due to the measure of
severity of illness utilised. The use of a clinical rating of severity such as the
Shwachman score (Shwachman, 1965) may have demonstrated different results. The
Shwachman score classifies patients into severe, moderate, mild, good and excellent
depending on their total score and the rating is based on the sum of scores across
four parameters: general activity, physical examination, nutrition and chest x-ray.
Many CF services complete this clinical rating of severity at each clinic
appointment, however, the Tayside and Forth Valley clinics did not consistently
utilise the Shwachman score and data was therefore unavailable for the majority of
the participants.
Moreover, Sensky (1990) reports that patients' reactions to chronic illnesses often
depends less upon the severity of the illness than upon the patients' attitude towards
the illness. Within this sample group the participants appear to have adjusted well to
their illness, have been encouraged to lead as normal a life as possible despite their
condition and have been well supported by their families and the CF team. This may
therefore have positively impacted on their ability to manage any deterioration in
health and may explain the findings. The hypothesis was not supported and various
possible reasons for this have been discussed. However, the sample size of this study
was small and a post-hoc power calculation suggested that there was approximately
a 16% chance of finding a significant relationship between severity of illness and
anxiety levels. Furthermore, there was approximately a 10% chance of detecting an
actual relationship between severity of illness and levels of depression. A larger
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sample would therefore be required in future studies in order to ascertain whether
there is indeed any association between increased severity of illness and
psychological distress.
4.5 DISCUSSION OF THE QUALITATIVE DATA
The aim of the qualitative analysis was to report the diversity of experiences amongst
adolescents and young adults with CF in line with the hypotheses of the study. In
particular, the impact that the condition had on their lifestyle, their emotional
reactions to their condition, reasons for adherence and non-adherence to regimens
and their relationships with health care providers. Due to the small numbers involved
in this part of the current study, no claim is made that the opinions expressed
represent the experiences of young people with CF in general. The most frequently
reported themes during the interviews concerned the importance of acceptance of the
condition and attempting to maintain a sense of normality to lessen the impact of the
condition on the individuals' lifestyles. In addition, establishing a routine for the
treatment regimens and emotional and practical support from parents, friends and
health care providers were considered to be extremely valuable and appeared to be
interrelated to adherence to regimens. The majority of respondents also described a
preference for a sense of autonomy within health care settings when discussing
treatment regimens. From the information gathered from the respondents during the
interviews, it is evident that within this sample group, having CF was perceived as
something that they had to learn to accept and live with. Contrary to expectations, the
majority of respondents did not report significant difficulties with anxiety or low
mood although the time-consuming nature of treatment regimens, particularly
physiotherapy, was a major cause of frustration for some in their lives.
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4.5.1 Discussion of the Qualitative Findings
An examination of the qualitative data indicated that having a chronic illness
disrupted school attendance due to prolonged absences because of poor health and
frequent hospital admissions, which in turn interfered with the participants'
academic work and limited their level of involvement with their peers. The majority
of participants, however, reported that their schools had been accommodating with
regard to their absences and had attempted to assist them to keep up to date with
their class work. They also reported that they had not been segregated or bullied at
school or made to feel particularly different from their peers. In relation to hospital
admissions for intravenous antibiotics or due to ill health, several of the respondents
reported missing their families whilst in hospital but generally found their time in
hospital to be tolerable. One respondent commented on feelings of isolation during
hospital admissions since they had to be segregated from other CF patients because
they had colonized Burkholderia cepacia. The respondent stated that they had
previously mixed with their CF peers and had discussed illness-related thoughts,
concerns and strategies regarding how to manage the condition with them.
Consequently, they had found their recent segregation difficult. However, the
respondent commented that they were still able to communicate with their peers via
e-mail which had been useful. The presence of Burkholderia cepacia in CF patients
has severely curtailed their opportunity for mutual support from other CF patients
due to the risk of cross infection for peers (LiPuma, Dasen, Nielson, Stern and Stull,
1990). New technology such as e-mail and internet support groups may therefore
prove valuable to these individuals to enable them to maintain communication whilst
avoiding face to face contact and prevent them from feeling as isolated.
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With regard to emotional well-being, five respondents spoke of the importance of
acceptance of their condition in maintaining their emotional well-being. Furthermore,
acceptance of the condition appeared to be linked to the importance of maintaining a
sense of normality. Six respondents considered this to be essential in dealing with
their CF. Acceptance of the condition and attempts to live as normal a life as possible
despite having CF were common strategies used by respondents in this group. With
the prospect of having a life-long condition with an unpredictable and limited life
expectancy, these are perhaps effective strategies for dealing with CF. These factors
also appeared to be related to reports by the majority of respondents that they did not
think about their future health in detail and instead tried to get on with and enjoy
their life as much as possible.
The majority of respondents also spoke of the importance of emotional and practical
support from significant others, including parents and health care providers, in
assisting them to manage their condition. This support was also perceived as valuable
in encouraging them to adhere to treatment. The qualitative data also suggested that
some of the respondents appeared to cope better with having CF than others as
indicated by the range of emotional reactions reported during the interviews.
Emotional reactions most frequently described included embarrassment about having
to take pancreatic enzymes within social situations, particularly within the school
environment, as this made participants feel different to their peers. Frustration at the
time-consuming nature of physiotherapy, the impact of intravenous antibiotics on




Having a chronic condition, like CF, can be very stressful for the whole family as the
mornings and evenings, in particular, are governed by treatments. Five respondents
described the importance of establishing a routine for treatments to allow them to
balance a normal life with their need for treatment. In relation to reasons for
adherence, four respondents commented on the importance of adhering to treatment
in order to maintain their health. The majority of respondents described feeling
confident in undertaking their treatment and reported that they had been provided
with sufficient information about treatments from their health care providers.
Moreover, although five respondents described low motivation to undertake
physiotherapy in particular, due to its time-consuming nature and the lack of any
immediate benefit, four of these individuals stated that their parents often encouraged
them to adhere with this regimen component and provided assistance with it.
The majority of respondents who attended the interviews generally perceived their
care providers to be autonomy supportive. They described being given choices about
their treatments and feeling that their viewpoints were understood and considered
themselves to have some autonomy with regard to decisions about their regimens,
particularly within the adult CF clinics. Respondents appeared to be satisfied with the
services received from the CF team care and many found the CF liaison nurses
particularly easy to talk to about a range ofmatters.
In general, the participants who attended the interviews seemed to have had positive
experiences with their health care providers and described supportive relationships
with their families and peers. Comments obtained from the interviews would suggest
that this support was important in promoting respondents' beliefs in their ability to
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adhere to their treatment regimens. These findings agree with Eiser (1993) who
stated that how a child adjusts to their illness is related to their health and their
family and social environment. Those participants interviewed perceived CF as part
of their life and treatment regimens generally appeared to be accommodated into
their lifestyle. It is possible that the individuals who declined to be interviewed, or
indeed participate in the study, may have given a different perspective of their
adaptation to the condition, their level of support from family, peers and health care
providers and their subsequent adherence to regimens.
Clearly not all the comments made during the interviews could be categorised into
the main themes given above. Those that have been identified demonstrate the extent
to which adolescents and young adults with CF deal with their condition and describe
factors associated with assisting the respondents to maintain self-management.
Individuals presenting with emotional difficulties in relation to their condition may
require psychological input to enhance their sense of control over the condition and
effectively manage the associated stresses (Hains et al, 1997). However, as
mentioned in the introduction, not all CF teams have a clinical psychologist within
their membership. The need for psychological input to be available for young people
with CF and the possible inclusion of a clinical psychologist within all CF teams is
an area that requires further investigation. Certainly discussions with the consultant
paediatricians and consultant respiratory physicians indicate a desire for resources to
be made available to enable this.
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4.5.2 Methodological Issues Relating to the Qualitative Data
It should be taken into consideration that the interpretation of the qualitative data in
the current study did not strictly adhere to any specific qualitative approach. The
coding of the transcript information could have been improved by utilising a more
formal method of identifying themes from the data such as grounded theory,
developed by Glaser and Strauss (1967). However, this was not possible due to the
time limitations of the study. In addition, an attempt was made to link qualitative and
quantitative concepts and therefore the interpretation of the information obtained
from the semi-structured interviews may have been compromised as themes were
primarily identified from previous research as opposed to being solely derived from
the data. Coding could have been further enhanced by a second researcher recoding
the transcripts thereby minimising researcher bias. However, investigation of inter-
rater reliability was not possible due to the time constraints of the study. The size of
the sample for the qualitative analysis also limits the extent to which the results and
themes can be generalised to the CF population and therefore the analysis of the
transcripts may only be pertinent to this particular sample group. Future research
within this area would require a larger sample to determine whether the themes
identified within this study were representative of the CF population as a whole.
Nevertheless, the use of semi-structured interviews, with open-ended questions,
allowed for detailed and interesting information regarding the personal experiences
of adolescents and young adults diagnosed with CF which augmented the
quantitative results obtained. Although the interviewer directed the structure of the
interview to an extent, it is unlikely that this diverse information would have been
obtained through the use of questionnaire methods alone.
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4.6 GENERAL METHODOLOGICAL ISSUES
With regard to the general methodological issues, there are several points that
warrant consideration and have implications for the interpretation of the results and
these will now be discussed.
4.6.1 The Recruitment ofParticipants
Difficulties were encountered in the recruitment of CF patients into the study and for
this reason the geographical area from which participants were recruited had to be
broadened. The study was well received by the consultant paediatricians and
consultant respiratory physicians within the two Health Boards as they considered it
to be pertinent to the recognised problems of non-adherence within CF services and
valuable in providing information regarding the possible influence of patient-
physician interactions to address the problem. However, the number of participants
who agreed to participate in the study fell considerably short of the numbers that had
initially been anticipated by the consultants, with a disappointing response rate of
22.4% and the consultants expressed surprise at the poor response. There may be
several reasons for the low response rate and these will be discussed in turn. In the
current study, questionnaires were posted to individuals due to time limitations,
however, as Lebow (1982) reports there is a tendency for low response rates
associated with studies involving postal questionnaires. In retrospect it may have
been beneficial to meet with selected individuals within the CF clinics, with ethical
approval, to issue the information sheets, consent forms and questionnaire packs as
this may have reduced any anxiety and have increased the likelihood of additional
responses. Individuals may also have been concerned about the confidentiality of
their responses, particularly as some of the measures used in the study required them
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to discuss their relationship with their health care providers. They may therefore have
been reluctant to participate, despite assurances of confidentiality of the information
received and emphasising that the researcher was not part of the CF team.
Another reason for the poor response rate may be due to the fact that CF requires
time-consuming regimens and regular visits to the paediatric and adult CF clinics.
The invitation to participate in the study may have been perceived by the CF patients
as an additional burden related to their condition, even though the completion of the
questionnaire pack was estimated to take approximately 30 minutes in total.
Furthermore, CF patients miss school more than their healthy peers due to ill health,
hospital admissions and clinic appointments and this can make it difficult for the
individual to keep up to date with their academic work (Fowler, Johnson and
Atkinson, 1985). At the time of recruitment many adolescents were in the process of
sitting examinations at school and therefore the study may have seemed like an
additional stressor prior to the examinations. Indeed, four individuals contacted the
researcher to state that they were currently revising for examinations and were
therefore unwilling to participate in the study.
Moreover, Suls and Fletcher (1985) have described two defence reactions exhibited
by individuals with chronic health conditions. The first is an avoidance response,
sometimes called 'denial', that is implemented in an attempt to minimise threat by
focusing attention away from the condition and consequently the individual may
show little interest in information about the disease or changes in the condition. The
other defence reaction is to monitor the disease and follow any changes in the disease
process closely and Suls and Fletcher state that individuals who implement this
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strategy may be more willing to talk openly about their condition. Strauss and
Wellisch (1981) found a prominent use of 'adaptive denial' amongst CF sufferers
and their families and claimed that although the negative reality of the illness was
recognised, patients and their families tried not to think about the condition more
than necessary and focused instead on daily activities. It may be that a proportion of
the non-responders utilise the avoidance response and were therefore discouraged
from participating in the study, as they did not wish to think of or speak about their
condition. In contrast, those individuals who participated in the study could possibly
be considered to fit the other defence strategy in view of their willingness to discuss
their condition and its effect on their lives. Further research investigating the reasons
for non-participation in CF-related studies may provide interesting information that
could be utilised to encourage future participation in studies.
4.6.2 The Generalisation of the Results
The low response rate to this study limits the conclusions that can be drawn from the
research and the extent to which the results can be generalised to the CF population.
In order to ascertain whether the individuals who participated in the study were
representative of the CF population as a whole, it would have been useful to obtain
demographic information on non-respondents. This was not possible, however, in
order to safeguard the confidentiality of patients, as the Medical Directors within
Tayside and Forth Valley NHS Health Boards granted Caldicott Guardian approval
to access the hospital case notes of only those individuals who gave informed
consent to participate in the study. Nevertheless, the quantitative and qualitative data




4.6.3 The Measure of Adherence Utilised
Rapoff (1999) states that there is no ideal measure of adherence at present, with all
techniques having at least some methodological limitations. However, he reports that
patient and parental estimates of adherence are regularly used within clinical
settings. Within this study, patient self-reports of adherence to four regimen
components were obtained. In order to aid recall, adherence was to be rated for the
previous week and, as suggested by Lask (1994), adherence behaviour was
conceptualised along a continuum. Furthermore, in an attempt to ensure that
estimates of adherence were accurate, it was emphasised that there were no right or
wrong answers and the confidentiality of responses was assured. Obtaining several
reports of adherence behaviour across different time periods may have provided
interesting information regarding possible variations of adherence across time,
although this was not possible due to time limitations of this study. Moreover, it may
have been worthwhile to obtain a provider estimate of adherence which could then
be compared with patients' self-reports and any discrepancies between these reports
subsequently investigated.
4.6.4 Time Delay Incurred whilst Awaiting Ethical Approval
Research ethics committees (RECs) have been criticised for the time delays incurred
by researchers whilst awaiting ethical approval to proceed with research (Cohen,
1999) and such a problem was encountered with this study. A research proposal for
the study was submitted to the Tayside Committee on Medical Research Ethics for
their committee meeting in December 2001. Approval to proceed was obtained,
subject to minor amendments, and the amended documentation was returned to the
secretary of the committee at the beginning of January 2002 for review. However,
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formal approval was not granted until seven weeks after the amendments were
submitted because of annual leave and sick leave of committee members which
resulted in a backlog of proposals. The starting date of the research was therefore
delayed which was particularly frustrating given the strict time limitations of the
study. Furthermore, due to the low response rate in Tayside an additional proposal
was submitted to the Forth Valley Ethics of Research Committee in April 2002.
Relatively minor amendments were requested, however, the researcher was invited
to discuss these amendments with the committee at the next meeting in May.
Although formal approval was granted following the meeting it was considered that
the issues could have been resolved by written correspondence thereby preventing a
further time delay to the study.
The importance of early submission of future proposals to RECs was recognised in
view of the possible time delays incurred. However, it is hoped that the guidelines
specified within the Department of Health Research Governance Framework,
introduced in April 2002, will reduce unnecessary time delays between receiving and
reviewing proposals or amendments, as RECs are now required to submit proposals
to another REC if delays are anticipated. RECs have also been criticised for the
diversity in practice between different Health Boards (Cohen, 1999). In the current
study different amendments were requested by the RECs within Tayside and Forth
Valley. The implementation of a standard protocol for ethical review, as proposed in




4.6.5 Post-Hoc Power Calculations
In view of results from a similar study by Howells et al (2001) that applied self-
determination theory within the asthma population, a large effect size was
anticipated. Power calculations suggested that at least 40 participants were required
to produce a large effect size for the statistical analysis used and the consultant
paediatricians and consultant respiratory physicians were confident that sufficient
participants could be recruited. Fewer participants were recruited than was
anticipated, however, and consequently post-hoc power calculations have been
calculated and discussed within this chapter. A continuation of this study with a
larger sample may result in additional, more robust findings.
4.7 CLINICAL IMPLICATIONS OF THE STUDY
4.7.1 Implications of the Study for Health Professionals in CF Teams
Despite the low response rate, the results of the study suggest that there is a
meaningful correlation between participants' perceptions of autonomy supportive
health care providers, participants' autonomous motivation to adhere to treatment
regimens and their self-efficacy. Increased self-efficacy is also associated with better
adherence to dietary aspects of the CF regimen. In view of the findings, the results of
the current study will be relayed to health care providers within the CF teams within
the two Health Boards where the study was conducted and a continuation of the
study with a larger sample recommended to confirm the findings.
Within the literature many studies have focused on the impact of patient, family and
regimen factors on adherence but relatively few have examined the role of the
patient-practitioner interaction. Clark et al (1995) posit that the physician-patient
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relationship is especially important in the management of chronic illness as the
physician helps the patient assume responsibility for implementing and actively
monitoring the therapeutic regimen and guides the patient when adjustments to the
regimen are required. The importance of a collaborative, supportive and non-
judgemental relationship between patients, family members and health care providers
on adherence is also advocated by the self-determination theory of human motivation
(Deci and Ryan, 1985).
Williams et al (2000) reviewed the literature concerning health care outcomes
associated with autonomy supportive patient care and concluded that when
physicians were more autonomy supportive than controlling, patients were likely to
display higher satisfaction with health care, better adherence to prescriptions, more
maintained behaviour change and better physical and psychological health. In view
of the research applying the self-determination theory to chronic conditions and the
preliminary results of this investigative study, it would seem appropriate to educate
members of the CF teams about the importance of autonomy supportive relationships
with patients to enable them to offer optimal support to young people with CF.
Westwood et al (1999) conducted a cross sectional study of adolescents and adults
with CF regarding their perspectives about the transition to adult CF clinics and
found that autonomy in health care was deemed to be 'extremely important' by 77%
of respondents. The qualitative data obtained in this study supports this finding with
a sense of autonomy within CF clinics being perceived as important by the majority
of respondents. Relationships between adolescents and young adults with CF and
their health care providers, where the patient feels a sense of autonomy and is
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provided with information to enable them to make informed decisions concerning
their adherence to prescribed regimens, appear to have a beneficial effect not only on
patients' motivation to adhere but also their confidence in their ability to take
responsibility for and carry out their treatments.
4.7.2 Implications for Improving Adherence to Treatment Regimens
Adolescents and young adults with chronic conditions have unique issues and
requirements and have to balance treatment regimens with everyday activities.
Rapoff (1999) states that attempts should therefore be made, where possible, to
negotiate treatment goals and reduce the complexity and intrusiveness of regimens to
suit the lifestyle of the individual and thereby improve the likelihood of adherence.
During the semi-structured interviews, one respondent commented on the positive
impact that negotiations about their regimen had on adherence: "I'm meant to use my
nebulizer four times a day but I often forget to or can't be bothered going home
during the day to do it...the doctor suggested that I try using it in the morning and at
night for twice as long as normal...that's easier to do because I already take my
tablets then anyway". The importance of negotiating regimens to consider the
lifestyle and social context of patients to maximise adherence will also be discussed
with the CF teams.
Within this study, increased self-efficacy appeared to be related to increased
adherence to dietary aspects of the CF regimen. Health care providers therefore
require to be informed of the importance of enhancing the self-efficacy of CF
patients regarding their ability to carry out treatment regimens. Bandura (1997)
posits that attempts to enhance self-efficacy are most effective if the provider is
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viewed as trustworthy, competent and autonomy supportive. He states that through
emphasising their belief that the patient is capable of doing the required tasks and
ensuring that the patient is successful in their efforts, health care providers can
increase patients' feelings of competence regarding their self-management.
Clinicians also need to be sensitive to concerns regarding regimen tasks since open
communication can lead to effective problem solving and consequently increase the
confidence of the patient to undertake the regimen components. During the semi-
structured interviews, two respondents reported that they had been apprehensive
about undertaking overnight feeds but had felt more able to carry out this task, with
the assistance of their parents, following discussions with the CF nurses regarding
their concerns: "The nurses made sure that my parents and I knew how to administer
the overnight feeds, that was helpful.. .we were more confident about doing it".
Czjakowski and Koocher (1987) found that adolescents with CF who believed that
their actions made a difference to their health displayed good levels of adherence to
their treatment. Kyngas and Barlow (1995) also reported that in addition to
increasing knowledge about health conditions and skills required to implement
treatments, there is also a need to improve the self-efficacy of the individual to
increase their confidence in their ability to carry out their self-care. In view of the
findings from the literature and the current study it would appear necessary to
monitor patients' self-efficacy within CF clinics and address low self-efficacy in
patients since this may impact on their adherence. However, although there have
been attempts to develop and validate illness-specific self-efficacy scales for children
and adolescents in diabetes and asthma, no such measures are presently available for
the CF population. Future research to develop or modify a self-efficacy measure for
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this client group would be beneficial. Moreover, patients' belief in the likelihood that
their efforts will reap positive benefits also appears to be important for their
adherence to regimens. Rapoff (1999) claims that clinicians should emphasise the
potential benefits of prescribed regimens, provide disease outcome information and
encourage patients to monitor symptoms to demonstrate the benefits of the
prescribed regimens.
4.8 FUTURE STUDIES
Throughout this chapter, suggestions for future research in relation to the hypotheses
outlined have been expanded upon. Additional areas for future investigation will
now be discussed. The qualitative data suggested that within this sample group,
adolescents and young adults with CF were relatively well adjusted to their condition
in terms of their emotional well-being. Detailed information was obtained from the
interview transcripts that indicated that several respondents viewed acceptance of
their condition as important in enabling them to maintain a sense of normality.
However, no measure of acceptance of illness was used in this study. Future research
could consider utilising the Acceptance of Illness Scale (AIS), developed by Felton,
Revenson & Hinrichsen (1984), that directly assesses adjustment to illness. If CF
patients are perceived as resilient and adaptable to their illness as found in this study
and also suggested by Angst (2001), possible reasons for this resilience could then
be examined in detail and the results applied to other chronic conditions.
In addition, although the application of the self-determination theory appears to be
relevant to CF patients, the conclusions drawn from this study will need to be
supported by further research using a larger sample of adolescents and young adults
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with CF. A longitudinal study examining the influence of autonomy supportive
health care provider relationship styles on patients' self efficacy, motivation to
adhere, subsequent adherence behaviours and health outcomes over a 6 and 12
month period would be recommended.
4.9 CONCLUSIONS
Non-adherence to treatment regimens in young people with CF and the subsequent
impact on health care resources, school and work absenteeism and long-term health
outcomes has been well documented within the literature. It is therefore important
that research examines factors likely to encourage maximum adherence within this
population. However, psychological research investigating the importance of health
care provider relationship styles on CF patients' motivation to adhere, self-efficacy
and consequent adherence to treatment regimens is still in its infancy. The results of
the current, investigative study suggest that young peoples' perceptions of autonomy
supportive health care providers were associated with an increase in their self-
efficacy, with participants' autonomous motivation acting as a mediating variable.
Furthermore, participants' increased self-efficacy was related to improved adherence
to the dietary aspects of the treatment regimen. Consequently, training in the
importance of autonomy supportive relationship styles should be undertaken within
CF services to enable providers to offer optimal support to young people with CF.
Further work, with a larger sample, is required to confirm that these factors are
influential in increasing adherence to regimens within this population since this will
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(1) The Health Care Climate Questionnaire (HCCQ)
(2) The Self-efficacy Questionnaire (SEQ)
(3) The Treatment Self-regulation Questionnaire (TSRQ)
(4) The Hospital Anxiety and Depression Scale (HADS)
(5) A Self-report Measure ofAdherence
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Questionnaire Pack
Please answer the following questions and then complete the
questionnaires below. There are no right or wrong answers and your
responses will be kept private
A) Are you Male or Female ?
B) How old are you ?
C) Which care provider do you see most often ? (please tick)
CF doctor CF nurse Both seen as often
1. What do you think about the people who help with your
Cystic Fibrosis?
These questions ask about how your care provider (e.g. CF doctor or nurse)
deals with you and your CF. Care providers have different styles in dealing with
CF patients. We would like to know more about how you feel about your
meetings with your care provider. Put a number in the box to show how much
you agree or not with the following statements.
1 =Strongly disagree 5 =Slightly agree
2 =Moderately disagree 6= Moderately agree
3 =Slightly disagree 7= Strongly agree
4 =Neutral
1. □ I feel that my care provider
has provided me with choices and
options.
2. □ I feel understood by my care
provider.
3. □ I am able to be open with my
care provider at our meetings.
4. □ My care provider conveys
confidence in my ability to make
changes.
5. □ I feel that my care provider
accepts me (regardless of how well
I look after my CF).
6. □ My care provider has made
sure that I really understand the
risks of my condition and what I
need to do, without pressuring me.
9. □ My care provider answers my
questions fully and carefully.
10. □ My care provider listens to how I
would like to do things.
11. □ My care provider handles my
emotions very well.
12. □ I feel that my care provider cares
about me as a person.
13. □ I don't feel very good about the
way my care provider speaks to
me.
14. □ My care provider tries to
understand how I see things
before suggesting a new way to do
things.
7. □ My care provider encourages 15. □ I am able to share my feelings
me to ask questions. wjtli my care provider.
8. □ I feel a lot of trust in my care
provider.
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2. How do you feel about your Cystic Fibrosis?
Put a number in the box to show how much you agree or not with the statements
1 =Strongly disagree 5 —Slightly agree
2 =Moderately disagree 6= Moderately agree
3 —Slightly disagree 7= Strongly agree
4 =Neutral
1. □ I feel confident in my ability to look after my CF.
2. □ I feel capable of handling my CF at the moment.
3. □ I am able to do my own routine CF care at the moment.
4. □ I am able to meet the challenge of looking after my CF.
3. Why do you look after your Cystic Fibrosis?
Think about the reasons why you look after your CF. Put a number in the box
to show how much you agree or not with the following statements.
1 =Strongly disagree 5 =S lightly agree
2 =Moderately disagree 6= Moderately agree
3 =Slightly disagree 7= Strongly agree
4 =Neutral
1. □ Other people would be mad at me if I didn't.
2. □ I find it a personal challenge to keep my CF well controlled.
3. □ I believe that tightly controlling my CF will greatly improve my health.
4. □ I would feel guilty if I didn't do what my doctor said.
5. □ I believe looking after my CF is the most important reason for me remaining
healthy.
6. □ Mostly, I want my doctor to think I'm a good patient.
7. □ Effectively looking after my CF is one of many important aspects of my life.
8. □ I would feel bad about myself if I didn't.
9. □ I feel personally satisfied when I keep my CF within strict guidelines.
10. □ It's rewarding to try to keep my lung function readings in a healthy range.
11. □ Managing my CF closely allows me to participate in other important aspects of
my life.
12. □ I don't want other people to be disappointed in me.
13. □ Taking my medication (tablets and/or nebulizers) and doing my physiotherapy
are a regular part of my life.
148
4. Read each item below and underline the reply which comes closest to how you have
been feeling in the past week. Don't take too long over your replies, your immediate reaction
to each item will probably be more accurate than a long thought-out response.
1. I feel tense or 'wound up'
Most of the time
A lot of the time
From time to time, occasionally
Not at all
2.1 still enjoy the things I used to enjoy
Definitely as much
Not quite so much
Only a little
Hardly at all
3. I get a sort of frightened feeling as if
something awful is about to happen
Very definitely and quite badly
Yes, but not too badly
A little, but it doesn't worry me
Not at all
4.1 can laugh and see the funny side of things
As much as I always could
Not quite so much now
Definitely not so much now
Not at all
5. Worrying thoughts go through my mind
A great deal of the time







Most of the time






8.1 feel as if I am slowed down




9.1 get a sort of frightened feeling





10. I have lost interest in my appearance
Definitely
I don't take as much care as I should
I may not take quite as much care
I take just as much care as ever






12.1 look forward with enjoyment to things
As much as I ever did
Rather less than I used to
Definitely less than I used to
Hardly at all











5. Do you look after your Cystic Fibrosis in the way you
are advised?
Draw a cross on the line at the point that shows how much you followed the CF
advice given to you by your care provider over the past week.
1) MEDICATION Everyday I often miss Never/1 frequently
(e.g. antibiotics) some days miss days
4 3 2 1 0
2) PHYSIOTHERAPY
Every day I often miss Never /1 only do my
some days physiotherapy if ill
4 3 2 1 0
3) DIET
(e.g. enzymes Every meal/snack Most meals/snacks Never
and vitamins)
4 3 2 1 0
4) EXERCISE Every day I often miss Never
some days
4 3 2 1 0
Would you say that the past week was a 'typical' week in terms of how much you
followed the CF advice given to you by your care provider ?
Yes / No (Please delete)
If no, please describe what happened during the past week:
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SAMPLE QUESTIONS FROM THE INTERVIEW
These are examples of the questions that were asked during the interviews. The
questions were not asked in any particular order and were flexible according to the
respondent's replies.
Background Information
Please could you start by telling me a bit about yourself ?
Who do you live with ?
How do you get on with your family ?
Where do/did you go to school ?
Are you working at the moment ? What do you do ?
Has having CF affected your schooling/work ? In what way ?
When did you find out you had CF ?
Emotional Well-being
How do you feel about having CF ?
What effect has CF had whilst you were growing up (on social life/relationships) ?
What do you find most useful in helping you deal with having CF ?
Has there ever been a time when you found it difficult to cope with having CF ?
Who have been the most helpful people to you over the years ? In what ways ?
Information regarding Treatment Regimens
What treatments do you require for your CF?
How confident do you feel about carrying out your treatments ?
Which treatments are you most/least confident about doing ? Please explain why.
Is there any additional information you would like about your treatments ?
Which treatments do you find easiest/most difficult to adhere to ? Please explain why.
What are some of the reasons why you might not carry out your treatments ?
Relationships with Health Care Providers
How would you describe your relationship with your care providers (CF doctor/nurse) ?
Have there ever been times when you have felt that you have been listened to/have been
understood by your care provider ?
If so, What happened ?
How did you feel ?
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Have there ever been times when you have felt that you have not been listened to/have
not been understood by your care provider ?
If so, What happened ?
How did you feel ?
What did you do ?
What would have made the situation better ?
Do you think that the services you receive at the paediatric/adult CF clinics could be
better in any way?
Concerns about the Future
What are your thoughts about the future ?
Do you have any worries about your future health ?
Who do you talk to about these worries ?
Additional Questions
Do you have any questions that you would like to ask regarding this interview or the









Age at diagnosis (in months):











FEV1 % predicted (average reading for the previous six months):
Prescribed treatment regimen for CF:
Any other relevant information:
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Clinical Psychology Department
Level 6, South Block




Re: Invitation to participate in a study looking at the relationship between
young people with cystic fibrosis and their health care providers and self-
reports of adherence to cystic fibrosis treatment regimens.
I am carrying out a study at Ninewells Hospital, Dundee with young people
who have cystic fibrosis. The study is being undertaken with Dr.
Mukhopadhyay and Dr. Winter's knowledge and support. You are invited to
take part in this study. I have enclosed an information sheet about the study, a
consent form, a questionnaire pack and a pre-paid envelope. If you would like
more information about the study or you have any questions then please do not
hesitate to contact me at the Clinical Psychology Department on (01382)
425612. If you decide that you would like to participate in the study then
please complete the consent form and questionnaire pack and return them in
the pre-paid envelope within the next two weeks.
Thank You
Jackie Squire





Level 6, South Block




Re: Invitation to participate in a study looking at the relationship between
young people with cystic fibrosis and their health care providers and self-
reports of adherence to cystic fibrosis treatment regimens.
I am carrying out a study at Stirling Royal Infirmary and Falkirk and District
Royal Infirmary with young people who have cystic fibrosis. The study is
being undertaken with Dr. MacFadyen's knowledge and support. You are
invited to take part in the study. I have enclosed an information sheet about the
study, a consent form, a questionnaire pack and a pre-paid envelope. If you
would like more information about the study or you have any questions then
please do not hesitate to contact me at the Clinical Psychology Department on
(01382) 425612. If you decide that you would like to participate in this study
then please complete the consent form and questionnaire pack and return them
in the pre-paid envelope within the next two weeks.
Thank You
Jackie Squire
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Research Information Sheet for Participants
I am carrying out a project with young people who have cystic fibrosis. The study is
being undertaken with Dr. Mukhopadhyay and Dr. Winter's knowledge and support.
You are invited to take part in the project that will look at factors that may be
important to young people to encourage them to adhere to their treatment. This
information sheet has been developed to help you to understand what the project is
about so that you can decide whether or not you want to take part.
What is the research project all about ?
I am interested in your views about meeting with your care provider (e.g. the
doctor/nurse at the Cystic Fibrosis Clinic) and what your care provider has told you
about your condition and its treatment. I am also interested in your thoughts and
feelings about having cystic fibrosis and how well you follow the advice from your
care provider and look after yourself. I hope that the information gathered will allow
me to provide better information to care providers about how to work with young
people to encourage them to adhere to their treatment.
What will I have to do ?
If you agree to take part in the study, you will be asked to fill out five short
questionnaires that will ask about your views on cystic fibrosis and how it affects
your daily life. The questionnaires will take approximately 30 minutes to complete in
total. There are no right or wrong answers to the questions. Not all of the questions in
the questionnaires may apply to you and the questions that may not apply to you do
not necessarily have to be answered. Your responses to the questionnaires are
confidential and your answers will not be shared with your care provider or your
parents/guardian. If you appear to be having difficulties in coping with your
condition, your care provider may be informed of this but only with your permission.
I will also need access to parts of your medical file to gather further information
about the treatments offered to you.
It is your choice whether or not you want to take part in this project. If you agree to
take part and then change your mind you can withdraw from the study, without giving
a reason, and it will not affect your future medical care in anyway. If you do want to
take part in the project then please sign the consent form and complete the
questionnaire pack and return them both in the pre-paid envelope provided within the
next two weeks. A copy of your consent form will be sent to your GP so they are
aware that you are assisting me with the project.
In addition to completing the questionnaires, you are invited to attend an interview to
discuss your experiences of having cystic fibrosis in some more detail. If you agree to
take part in the interview, I will arrange to meet with you on one occasion at your
home or Ninewells Hospital, Dundee, whichever is most convenient for you, for
approximately 40 minutes. The information obtained during this meeting will be
confidential. The interview will be tape recorded with your consent and the audio
tapes will be destroyed at the end of the study.
What if I want any more information before making a decision ?
If you have any questions about this information sheet or you would like more
information about the project then please do not hesitate to contact me at the Clinical
Psychology Department, Ninewells Hospital on (01382) 425612.
Thank you for taking the time to read this information sheet.
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Research Information Sheet for Participants
I am carrying out a project with young people who have cystic fibrosis. The study is
being undertaken with Dr. MacFadyen's knowledge and support. You are invited to
take part in the project that will look at factors that may be important to young people
to encourage them to adhere to their treatment. This information sheet has been
developed to help you to understand what the project is about so that you can decide
whether or not you want to take part.
What is the research project all about ?
I am interested in your views about meeting with your care provider (e.g. the
doctor/nurse at the Cystic Fibrosis Clinic) and what your care provider has told you
about your condition and its treatment. I am also interested in your thoughts and
feelings about having cystic fibrosis and how well you follow the advice from your
care provider and look after yourself. I hope that the information gathered will allow
me to provide better information to care providers about how to work with young
people to encourage them to adhere to their treatment.
What will 1 have to do ?
If you agree to take part in the study, you will be asked to fill out five short
questionnaires that will ask about your views on cystic fibrosis and how it affects
your daily life. The questionnaires will take approximately 30 minutes to complete in
total. There are no right or wrong answers to the questions. Not all of the questions in
the questionnaires may apply to you and the questions that may not apply to you do
not necessarily have to be answered. Your responses to the questionnaires are
confidential and your answers will not be shared with your care provider or your
parents/guardian. If you appear to be having difficulties in coping with your
condition, your care provider may be informed of this but only with your permission.
I will also need access to parts of your medical file to gather further information
about the treatments offered to you.
It is your choice whether or not you want to take part in this project. If you agree to
take part and then change your mind you can withdraw from the study, without giving
a reason, and it will not affect your future medical care in anyway. If you do want to
take part in the project then please sign the consent form and complete the
questionnaire pack and return them both in the pre-paid envelope provided within the
next two weeks. A copy of your consent form will be sent to your GP so they are
aware that you are assisting me with the project.
In addition to completing the questionnaires, you are invited to attend an interview to
discuss your experiences of having cystic fibrosis in some more detail. If you agree to
take part in the interview, I will arrange to meet with you on one occasion at your
home, Stirling Royal Infirmary or Falkirk and District Royal Infirmary, whichever is
most convenient for you, for approximately 40 minutes. The information obtained
during this meeting will be confidential. The interview will be tape recorded with
your consent and the audio tapes will be destroyed at the end of the study.
What if I want any more information before making a decision ?
If you have any questions about this information sheet or you would like more
information about the project then please do not hesitate to contact me at the Clinical
Psychology Department, Ninewells Hospital on (01382) 425612.








The relationship between young people with cystic fibrosis and their health care
providers and self-reports of adherence to cystic fibrosis treatment regimens.
Name of Researcher:
Jackie Squire (under the supervision of Lesley Howells)
Please Tick
1) I confirm that I have read and understood the information sheet for the above ! |
study and have had the opportunity to ask questions.
□
□
2) I understand that my participation is voluntary and that 1 am free to withdraw
at any time, without giving a reason, without my medical care or legal rights
being affected.
3) I understand that sections ofmy medical notes will be looked at by Jackie,
Squire, Clinical Psychologist in Training, where it is relevant to my taking
part in the research. I give permission for this individual to have access to
my records and to use the information on the understanding that all identifying
features will be removed to ensure anonymity.
4) I agree to take part in the study.
5) I agree to be interviewed and agree to the interview being tape recorded on I
the understanding that the tape is destroyed at the end of the study.
Name of patient
Signature Date
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REPLY SLIP FOR THE INTERVIEW
I would / would not be willing to be interviewed about my experiences of having
cystic fibrosis (Please delete)
If you have decided to take part in the interview then please complete the following
sections and return this form with the completed consent form and questionnaire
pack in the pre-paid envelope provided within the next two weeks. If you do not
wish to take part in the interview then you do not need to return this form.
Name:
Telephone number:
Best day and time for appointment (Please tick)
Monday Tuesday Wednesday Thursday Friday Any Day
a.m.
p.m.
Are there any days that would be unsuitable over the next month ?
Thank you.
Jackie Squire
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Clinical Psychology Department
Level 6, South Block





The above named individual has given their consent to participate in the
following research project: The relationship between young people with
cystic fibrosis and their health care providers and self-reports of
adherence to cystic fibrosis treatment regimens.
The study will be undertaken at Ninewells Hospital, Dundee from April 2002
until July 2002. If you would like further information or have any questions
about the research project then please do not hesitate to contact me at the
Clinical Psychology Department on (01382) 425612.
I have enclosed a copy of [patient's name] signed consent form for your files.
Yours sincerely
Jackie Squire





Level 6, South Block





The above named individual has given their consent to participate in the
following research project: The relationship between young people with
cystic fibrosis and their health care providers and self-reports of
adherence to cystic fibrosis treatment regimens.
The study will be undertaken at Stirling Royal Infirmary and Falkirk and
District Infirmary from May 2002 until July 2002. If you would like further
information or have any questions about the research project then please do
not hesitate to contact me at the Clinical Psychology Department on (01382)
425612.
I have enclosed a copy of [patient's name] signed consent form for your files.
Yours sincerely
Jackie Squire
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*This letter was sent to parents/guardians if their son/daughter was under 16 years of age.
Clinical Psychology Department
Level 6, South Block




Re: Invitation to participate in a study looking at the relationship between
young people with cystic fibrosis and their health care providers and self-
reports of adherence to cystic fibrosis treatment regimens.
I am carrying out a study at Ninewells Hospital, Dundee with young people
who have cystic fibrosis. The study is being undertaken with Dr.
Mukhopadhyay and Dr. Winter's knowledge and support. Your [son/daughter]
is invited to take part in this study. I have enclosed an information sheet about
the study for your perusal in addition to a consent form, a questionnaire pack
and a pre-paid envelope. If you would like more information about the study
or you have any questions then please do not hesitate to contact me at the
Clinical Psychology Department on (01382) 425612. If you are happy for your
[son/daughter] to participate in the study, please countersign the consent form
and give the questionnaire pack to your [son/daughter] for completion. It
would be appreciated if the completed consent form and questionnaire pack
could be returned in the pre-paid envelope within the next two weeks.
Thank You
Jackie Squire




*This letter was sent to parents/guardians if their son/daughter was under 16 years of age.
Clinical Psychology Department
Level 6, South Block




Re: Invitation to participate in a study looking at the relationship between
young people with cystic fibrosis and their health care providers and self-
reports of adherence to cystic fibrosis treatment regimens.
I am carrying out a study at Stirling Royal Infirmary and Falkirk and District
Royal Infirmary with young people who have cystic fibrosis. The study is
being undertaken with Dr. MacFadyen's knowledge and support. Your
[son/daughter] is invited to take part in this study. I have enclosed an
information sheet about the study for your perusal in addition to a consent
form, a questionnaire pack and a pre-paid envelope. If you would like more
information about the study or you have any questions then please do not
hesitate to contact me at the Clinical Psychology Department on (01382)
425612. If you are happy for your [son/daughter] to participate in the study,
please countersign the consent form and give the questionnaire pack to your
[son/daughter] for completion. It would be appreciated if the completed
consent form and questionnaire pack could be returned in the pre-paid
envelope within the next two weeks.
Thank You
Jackie Squire
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*This information sheet was sent to parents/guardians if their son/daughter was under 16 years of age.
Research Information Sheet for Parent/Guardian
I am carrying out a project with young people who have cystic fibrosis. The study is
being undertaken with Dr. Mukhopadhyay and Dr. Winter's knowledge and support.
Your [son/daughter] is invited to take part in the project that will look at factors that
may be important to young people to encourage them to adhere to their treatment. This
information sheet has been developed for your perusal to help you to understand what
the project is about so that you can decide whether or not you are in agreement with
your [son/daughter] taking part.
What is the research project all about ?
I am interested in the views of your [son/daughter] about meeting with their care
provider (e.g. the doctor/nurse at the Cystic Fibrosis Clinic) and what their care
provider has told them about their condition and its treatment. I am also interested in
your [son/daughter]'s thoughts and feelings about having cystic fibrosis and how well
they follow the advice from their care provider and look after themself. I hope that the
information gathered will enable me to provide better information to care providers
about how to work with young people to encourage them to adhere to their treatment.
What will my [son/daughter] have to do ?
If you are in agreement with your [son/daughter] taking part in the study, they will be
asked to complete five short questionnaires that will ask your [son/daughter] about their
views on cystic fibrosis and how it affects their daily life. The questionnaires will take
approximately 30 minutes to complete in total. Your [son/daughter]'s responses to the
questionnaires are confidential and their answers will not be shared with their care
provider or yourselves, in order to increase the likelihood that they will answer the
questionnaires honestly. If your [son/daughter] appears to be having difficulties in
coping with their condition, their care provider may be informed but only with your
[son/daughter]'s permission. I will also need access to parts of your [son/daughter]'s
medical file to gather further information about the treatments offered to them.
Your [son/daughter] can choose whether or not they want to take part in this project. If
they agree to take part and then change their mind they can withdraw from the study,
without having to give a reason, and it will not affect their future medical care in
anyway. If your [son/daughter] wants to take part in the project and you are in
agreement with this, then please can your [son/daughter] sign the consent form. As your
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[son/daughter] is under 16 years of age, please could you also sign the consent form as
their parent/guardian. The questionnaire pack should then be completed by your
[son/daughter] and be returned with the signed consent form in the pre-paid envelope
provided within the next two weeks. A copy of the consent form will be sent to your
[son/daughter]'s GP so that their GP is aware that they are assisting me with the
project.
In addition to completing the questionnaires, your [son/daughter] is invited to attend an
interview to discuss their experiences of having cystic fibrosis in some more detail. If
your [son/daughter] agrees to take part in the interview, I will arrange to meet with
them on one occasion at their home or Ninewells Hospital, Dundee, whichever is most
convenient, for approximately 40 minutes. The information obtained during this
meeting will be confidential. The interview will be tape recorded with both you and
your [son/daughter]'s consent and the audio tapes will be destroyed at the end of the
study.
What if I want more information before making a decision ?
If you have any questions about this information sheet or you would like more
information about the project then please do not hesitate to contact me at the Clinical
Psychology Department, Ninewells Hospital on (01382) 425612.
Thank you for taking the time to read this information sheet.
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*This information sheet was sent to parents/guardians if their son/daughter was under 16 years of age.
Research Information Sheet for Parent/Guardian
I am carrying out a project with young people who have cystic fibrosis. The study is
being undertaken with Dr. MacFadyen's knowledge and support. Your [son/daughter]
is invited to take part in the project that will look at factors that may be important to
young people to encourage them to adhere to their treatment. This information sheet
has been developed for your perusal to help you to understand what the project is about
so that you can decide whether or not you are in agreement with your [son/daughter]
taking part.
What is the research project all about ?
I am interested in the views of your [son/daughter] about meeting with their care
provider (e.g. the doctor/nurse at the Cystic Fibrosis Clinic) and what their care
provider has told them about their condition and its treatment. I am also interested in
your [son/daughter]'s thoughts and feelings about having cystic fibrosis and how well
they follow the advice from their care provider and look after themself. I hope that the
information gathered will enable me to provide better information to care providers
about how to work with young people to encourage them to adhere to their treatment.
What will my [son/daughter] have to do ?
If you are in agreement with your [son/daughter] taking part in the study, they will be
asked to complete five short questionnaires that will ask your [son/daughter] about their
views on cystic fibrosis and how it affects their daily life. The questionnaires will take
approximately 30 minutes to complete in total. Your [son/daughter]'s responses to the
questionnaires are confidential and their answers will not be shared with their care
provider or yourselves, in order to increase the likelihood that they will answer the
questionnaires honestly. If your [son/daughter] appears to be having difficulties in
coping with their condition, their care provider may be informed but only with your
[son/daughter]'s permission. I will also need access to parts of your [son/daughter]'s
medical file to gather further information about the treatments offered to them.
Your [son/daughter] can choose whether or not they want to take part in this project. If
they agree to take part and then change their mind they can withdraw from the study,
without having to give a reason, and it will not affect their future medical care in
anyway. If your [son/daughter] wants to take part in the project and you are in
agreement with this, then please can your [son/daughter] sign the consent form. As your
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[son/daughter] is under 16 years of age, please could you also sign the consent form as
their parent/guardian. The questionnaire pack should then be completed by your
[son/daughter] and be returned with the signed consent form in the pre-paid envelope
provided within the next two weeks. A copy of the consent form will be sent to your
[son/daughter]'s GP so that their GP is aware that they are assisting me with the
project.
In addition to completing the questionnaires, your [son/daughter] is invited to attend an
interview to discuss their experiences of having cystic fibrosis in some more detail. If
your [son/daughter] agrees to take part in the interview, I will arrange to meet with
them on one occasion at their home, Stirling Royal Infirmary or Falkirk and District
Royal Infirmary, whichever is most convenient, for approximately 40 minutes. The
information obtained during this meeting will be confidential. The interview will be
tape recorded with both you and your [son/daughter]'s consent and the audio tapes will
be destroyed at the end of the study.
What if I want more information before making a decision ?
If you have any questions about this information sheet or you would like more
information about the project then please do not hesitate to contact me at the Clinical
Psychology Department, Ninewells Hospital on (01382) 425612.
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Clinical Psychology Department
Level 6, South Block




Re: Study looking at the relationship between young people with cystic fibrosis
and their health care providers and self-reports of adherence to cystic fibrosis
treatment regimens.
I wrote to you in April 2002 regarding a study that I am undertaking at Ninewells
Hospital, Dundee with Dr Mukhopadyay and Dr. Winter's knowledge and support.
The study aims to look at factors that may be important to young people to encourage
them to adhere to their treatment for cystic fibrosis. The first stage of the study will
require you to complete five questionnaires that will take approximately 30 minutes
in total. The second stage of the study will involve meeting with you for an interview
lasting approximately 40 minutes to discuss your experiences of having cystic fibrosis
in some more detail.
■ If you do not wish to participate in the study or you have already returned the
signed consent form and completed questionnaire pack in the pre-paid envelope
then please ignore this reminder letter.
■ If you have not yet returned the signed consent form and would like additional
information about the study then please do not hesitate to contact me at the
Clinical Psychology Department, Ninewells Hospital on (01382) 425612.
■ If you are reluctant to meet with myself to discuss your experiences in detail but
are happy to complete the questionnaires at home, please could you ensure that
the signed consent form and completed questionnaire pack are returned in the
pre-paid envelope provided within the next two weeks.
Thank you for your co-operation.
Jackie Squire
(Clinical Psychologist in Training with Dr. Lesley Howells, Clinical Psychologist).
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*This letter was sent to parents/guardians if their son/daughter was under 16 years of age.
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Re: Study looking at the relationship between young people with cystic fibrosis
and their health care providers and self-reports of adherence to cystic fibrosis
treatment regimens.
I wrote to you in April 2002 regarding a study that 1 am undertaking at Ninewells
Hospital, Dundee with Dr. Mukhopadyay and Dr. Winter's knowledge and support.
The study aims to look at factors that may be important to young people to encourage
them to adhere to their treatment for cystic fibrosis. The first stage of the study will
require your [son/daughter] to complete five questionnaires that will take
approximately 30 minutes in total. The second stage of the study will involve meeting
with your [son/daughter] for an interview lasting approximately 40 minutes to discuss
their experiences of having cystic fibrosis in some more detail.
■ If you do not wish your [son/daughter] to participate in the study or you have
already returned the signed consent form and completed questionnaire pack in the
pre-paid envelope then please ignore this reminder letter.
■ If you have not yet returned the signed consent form and would like additional
information about the study then please do not hesitate to contact me at the
Clinical Psychology Department, Ninewells Hospital on (01382) 425612.
■ If your [son/daughter] is reluctant to meet with myself to discuss their experiences
in detail but are happy to complete the questionnaires at home, please could you
ensure that the signed consent form and completed questionnaire pack are
returned in the pre-paid envelope provided within the next two weeks.
Thank you for your co-operation.
Jackie Squire
(Clinical Psychologist in Training with Dr. Lesley Howells, Clinical Psychologist).
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Re: Study looking at the relationship between young people with cystic fibrosis
and their health care providers and self-reports of adherence to cystic fibrosis
treatment regimens.
I wrote to you at the beginning ofMay 2002 regarding a study that I am undertaking
at Stirling Royal Infirmary and Falkirk and District Royal Infirmary, with Dr.
MacFadyen's knowledge and support. The study aims to look at factors that may be
important to young people to encourage them to adhere to their treatment for cystic
fibrosis. The first stage of the study will require you to complete five questionnaires
that will take approximately 30 minutes in total. The second stage of the study will
involve meeting with you for an interview lasting approximately 40 minutes to
discuss your experiences of having cystic fibrosis in some more detail.
■ If you do not wish to participate in the study or you have already returned the
signed consent form and completed questionnaire pack in the pre-paid envelope
then please ignore this reminder letter.
■ If you have not yet returned the signed consent form and would like additional
information about the study then please do not hesitate to contact me at the
Clinical Psychology Department, Ninewells Hospital on (01382) 425612.
■ If you are reluctant to meet with myself to discuss your experiences in detail
but are happy to complete the questionnaires at home, please could you ensure
that the signed consent form and completed questionnaire pack are returned in
the pre-paid envelope provided within the next two weeks.
Thank you for your co-operation.
Jackie Squire
(Clinical Psychologist in Training with Dr. Lesley Howells, Clinical Psychologist).
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Re: Study looking at the relationship between young people with cystic fibrosis
and their health care providers and self-reports of adherence to cystic fibrosis
treatment regimens.
I wrote to you at the beginning ofMay 2002 regarding a study that I am undertaking
at Stirling Royal Infirmary and Falkirk and District Royal Infirmary, with Dr.
MacFadyen's knowledge and support. The study aims to look at factors that may be
important to young people to encourage them to adhere to their treatment for cystic
fibrosis. The first stage of the study will require your [son/daughter] to complete five
questionnaires that will take approximately 30 minutes in total. The second stage of
the study will involve meeting with your [son/daughter] for an interview lasting
approximately 40 minutes to discuss their experiences of having cystic fibrosis in
some more detail.
■ If you do not wish your [son/daughter] to participate in the study or you have
already returned the signed consent form and completed questionnaire pack in
the pre-paid envelope then please ignore this reminder letter.
■ If you have not yet returned the signed consent form and would like additional
information about the study then please do not hesitate to contact me at the
Clinical Psychology Department, Ninewells Hospital on (01382) 425612.
■ If your [son/daughter] is reluctant to meet with myself to discuss their
experiences in detail but are happy to complete the questionnaires at home,
please could you ensure that the signed consent form and completed
questionnaire pack are returned in the pre-paid envelope provided within the
next two weeks.
Thank you for your co-operation.
Jackie Squire




Graphs of Participants' Demographic Details
(1) Age of Participants from Tayside and Forth Valley
(2) Severity of Illness of Participants from Tayside and Forth Valley
(3) Social Deprivation Categories of Participants from Tayside and Forth Valley
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(1) Graph of age of participants from Tayside and Forth Valley (n=15)




(2) Graph of severity of illness of participants from Tayside and Forth Valley (n=15)
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(3) Graph of social deprivation categories of participants from Tayside and Forth
Valley (n=15)
2 3 4 5 6
Social deprivation category
□ Tayside
□ Forth Valley
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